UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED ~~September 30,~~December 31, 2023.

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM _______ TO _______.


000-25734
(Commission File Number)

Pyxus International, Inc.

(Exact name of registrant as specified in its charter)


Virginia		85-2386250
(State or other jurisdiction of incorporation)		(I.R.S. Employer Identification No.)

6001 Hospitality Court, Suite 100
Morrisville,	North Carolina	27560
(Address of principal executive offices)		(Zip Code)

(919) 379-4300

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act: None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐

Non-accelerated filer ☒

Accelerated filer ☐

Smaller reporting company ☒

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Indicate by check mark if the registrant has filed all documents and reports required to be filed under Sections 12, 13, or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court. Yes ☒ No ☐

As of ~~October~~January 31, ~~2023,~~2024, the registrant had 24,999,947 shares outstanding of Common Stock (no par value).

Pyxus International, Inc. and Subsidiaries

Table of Contents

Page No.

Part I.

Financial Information

Item 1.

Financial Statements (Unaudited)

Condensed Consolidated Statements of Operations

Condensed Consolidated Statements of Comprehensive Income (Loss)

Condensed Consolidated Balance Sheets

Condensed Consolidated Statements of Stockholders’ Equity

Condensed Consolidated Statements of Cash Flows

Notes to Condensed Consolidated Financial Statements

Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

2223

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

3031

Item 4.

Controls and Procedures

Part II.

Item 1.

Item 1A.

Item 5.

Item 6.

Part I. Financial Information

Item 1. Financial Statements


Pyxus International, Inc. and Subsidiaries	Pyxus International, Inc. and Subsidiaries									Pyxus International, Inc. and Subsidiaries
Condensed Consolidated Statements of Operations	Condensed Consolidated Statements of Operations									Condensed Consolidated Statements of Operations
(Unaudited)	(Unaudited)									(Unaudited)

		Three Months Ended				Six Months Ended
		September 30,
		Three Months Ended
		Three Months Ended
		Three Months Ended											Nine Months Ended
	December 31,													December 31,			December 31,
(in thousands, except per share data)	(in thousands, except per share data)	2023		2022		2023		2022		(in thousands, except per share data)	2023	2022	2023		2022
Sales and other operating revenues	Sales and other operating revenues	$	624,253	$	508,278	$	1,101,345	$	852,183
Cost of goods and services sold	Cost of goods and services sold	535,587		440,959		939,534		744,109
Gross profit	Gross profit	88,666		67,319		161,811		108,074
Selling, general, and administrative expenses	Selling, general, and administrative expenses	40,033		34,987		74,096		69,575
Other expense, net	Other expense, net	1,089		1,151		3,713		66
Restructuring and asset impairment charges	Restructuring and asset impairment charges	1,254		4,045		1,294		4,345

Operating income	Operating income	46,290		27,136		82,708		34,088
Operating income
Operating income

Loss on deconsolidation/disposition of subsidiaries

Loss on deconsolidation/disposition of subsidiaries

Loss on deconsolidation/disposition of subsidiaries	Loss on deconsolidation/disposition of subsidiaries	—		49		—		648
Loss on pension settlement	Loss on pension settlement	—		2,588		—		2,588
Interest expense, net	Interest expense, net	32,947		28,814		63,791		54,288

Income (loss) before income taxes and other items	Income (loss) before income taxes and other items	13,343		(4,315)		18,917		(23,436)
Income tax expense (benefit)		7,558		(1,210)		10,204		(2,077)
Income (loss) from unconsolidated affiliates		2,111		1,555		(47)		5,304

Income (loss) before income taxes and other items

Income (loss) before income taxes and other items
Income tax expense
Income from unconsolidated affiliates
Net income (loss)	Net income (loss)	7,896		(1,550)		8,666		(16,055)
Net (loss) income attributable to noncontrolling interests		(199)		(13)		(233)		145
Net income attributable to noncontrolling interests
Net income (loss) attributable to Pyxus International, Inc.	Net income (loss) attributable to Pyxus International, Inc.	$	8,095	$	(1,537)	$	8,899	$	(16,200)

Earnings (loss) per share:	Earnings (loss) per share:
Earnings (loss) per share:
Earnings (loss) per share:
Basic and diluted
Basic and diluted
Basic and diluted	Basic and diluted	$	0.32	$	(0.06)	$	0.36	$	(0.65)

Weighted average number of shares outstanding:	Weighted average number of shares outstanding:

Weighted average number of shares outstanding:

Weighted average number of shares outstanding:
Basic and diluted
Basic and diluted
Basic and diluted	Basic and diluted	25,000		25,000		25,000		25,000
																See "Notes to Condensed Consolidated Financial Statements"
See "Notes to Condensed Consolidated Financial Statements"

See "Notes to Condensed Consolidated Financial Statements"


Pyxus International, Inc. and Subsidiaries	Pyxus International, Inc. and Subsidiaries									Pyxus International, Inc. and Subsidiaries
Condensed Consolidated Statements of Comprehensive Income (Loss)	Condensed Consolidated Statements of Comprehensive Income (Loss)									Condensed Consolidated Statements of Comprehensive Income (Loss)
(Unaudited)	(Unaudited)									(Unaudited)

		Three Months Ended				Six Months Ended
		September 30,
		Three Months Ended
		Three Months Ended
		Three Months Ended											Nine Months Ended
	December 31,													December 31,		December 31,
(in thousands)	(in thousands)	2023		2022		2023		2022		(in thousands)	2023	2022	2023		2022
Net income (loss)	Net income (loss)	$	7,896	$	(1,550)	$	8,666	$	(16,055)

Other comprehensive loss, net of tax:
Other comprehensive income (loss), net of tax:
Other comprehensive income (loss), net of tax:
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment
Foreign currency translation adjustment
Foreign currency translation adjustment	Foreign currency translation adjustment	(1,545)		(4,801)		(838)		(3,854)
Pension and other postretirement benefit plans	Pension and other postretirement benefit plans	—		(1,562)		—		(1,562)

Cash flow hedges	Cash flow hedges	(1,000)		(1,768)		(138)		(3,271)
Cash flow hedges
Cash flow hedges

Total other comprehensive loss, net of tax		(2,545)		(8,131)		(976)		(8,687)
Total other comprehensive income (loss), net of tax
Total other comprehensive income (loss), net of tax
Total other comprehensive income (loss), net of tax
Total comprehensive income (loss)	Total comprehensive income (loss)	5,351		(9,681)		7,690		(24,742)
Comprehensive (loss) income attributable to noncontrolling interests		(199)		(13)		(233)		145
Comprehensive income attributable to noncontrolling interests
Comprehensive income (loss) attributable to Pyxus International, Inc.	Comprehensive income (loss) attributable to Pyxus International, Inc.	$	5,550	$	(9,668)	$	7,923	$	(24,887)

See "Notes to Condensed Consolidated Financial Statements"	See "Notes to Condensed Consolidated Financial Statements"
See "Notes to Condensed Consolidated Financial Statements"
See "Notes to Condensed Consolidated Financial Statements"


Pyxus International, Inc. and Subsidiaries Condensed Consolidated Balance Sheets (Unaudited)	Pyxus International, Inc. and Subsidiaries Condensed Consolidated Balance Sheets (Unaudited)							Pyxus International, Inc. and Subsidiaries Condensed Consolidated Balance Sheets (Unaudited)

(in thousands)	(in thousands)	September 30, 2023		September 30, 2022		March 31, 2023

(in thousands)

(in thousands)									December 31, 2023	December 31, 2022	March 31, 2023
Assets	Assets
Current assets	Current assets
Current assets
Current assets
Cash and cash equivalents
Cash and cash equivalents
Cash and cash equivalents	Cash and cash equivalents	$	112,098	$	114,082	$	136,733
Restricted cash	Restricted cash	5,572		1,691		2,176
Trade receivables, net	Trade receivables, net	233,679		205,024		185,351
Other receivables	Other receivables	27,664		15,550		17,387
Inventories, net	Inventories, net	877,154		890,097		775,071
Advances to tobacco suppliers, net	Advances to tobacco suppliers, net	67,641		48,712		42,305
Recoverable income taxes	Recoverable income taxes	5,090		11,970		5,815
Prepaid expenses	Prepaid expenses	36,844		35,069		37,555
Other current assets	Other current assets	15,179		15,863		18,172
Total current assets	Total current assets	1,380,921		1,338,058		1,220,565
Investments in unconsolidated affiliates	Investments in unconsolidated affiliates	87,042		88,695		100,750
Other intangible assets, net	Other intangible assets, net	36,251		40,892		38,572
Deferred income taxes, net	Deferred income taxes, net	15,768		16,691		6,662
Long-term recoverable income taxes	Long-term recoverable income taxes	3,410		4,560		2,863
Other noncurrent assets	Other noncurrent assets	46,206		44,025		43,761
Right-of-use assets	Right-of-use assets	39,139		33,042		35,892
Property, plant, and equipment, net	Property, plant, and equipment, net	133,717		132,102		133,398
Total assets	Total assets	$	1,742,454	$	1,698,065	$	1,582,463

Liabilities and Stockholders’ Equity	Liabilities and Stockholders’ Equity
Liabilities and Stockholders’ Equity
Liabilities and Stockholders’ Equity
Current liabilities	Current liabilities
Current liabilities
Current liabilities
Notes payable
Notes payable
Notes payable	Notes payable	$	570,036	$	548,490	$	382,544
Accounts payable	Accounts payable	153,152		103,494		170,287

Advances from customers
Advances from customers
Advances from customers	Advances from customers	46,056		43,802		42,472
Accrued expenses and other current liabilities	Accrued expenses and other current liabilities	93,981		75,993		92,693
Income taxes payable	Income taxes payable	12,585		5,262		18,264
Operating leases payable	Operating leases payable	8,380		8,644		8,723
Current portion of long-term debt	Current portion of long-term debt	20,232		140		75
Total current liabilities	Total current liabilities	904,422		785,825		715,058
Long-term taxes payable	Long-term taxes payable	2,678		5,783		4,978
Long-term debt	Long-term debt	573,959		646,125		618,430
Deferred income taxes	Deferred income taxes	10,225		11,576		9,900
Liability for unrecognized tax benefits	Liability for unrecognized tax benefits	20,170		14,660		14,175
Long-term leases	Long-term leases	28,171		23,580		25,581
Pension, postretirement, and other long-term liabilities	Pension, postretirement, and other long-term liabilities	52,816		56,939		52,511
Total liabilities	Total liabilities	1,592,441		1,544,488		1,440,633
Commitments and contingencies	Commitments and contingencies							Commitments and contingencies
Stockholders’ equity	Stockholders’ equity
Common Stock—no par value:	Common Stock—no par value:
Common Stock—no par value:
Common Stock—no par value:
Authorized shares (250,000 for all periods)	Authorized shares (250,000 for all periods)
Authorized shares (250,000 for all periods)
Authorized shares (250,000 for all periods)
Issued shares (25,000 for all periods)
Issued shares (25,000 for all periods)
Issued shares (25,000 for all periods)	Issued shares (25,000 for all periods)	390,290		390,290		390,290
Retained deficit	Retained deficit	(249,055)		(235,013)		(257,954)
Accumulated other comprehensive income (loss)	Accumulated other comprehensive income (loss)	4,539		(4,883)		5,515
Total stockholders’ equity of Pyxus International, Inc.	Total stockholders’ equity of Pyxus International, Inc.	145,774		150,394		137,851
Noncontrolling interests	Noncontrolling interests	4,239		3,183		3,979
Total stockholders’ equity	Total stockholders’ equity	150,013		153,577		141,830
Total liabilities and stockholders’ equity	Total liabilities and stockholders’ equity	$	1,742,454	$	1,698,065	$	1,582,463
								See "Notes to Condensed Consolidated Financial Statements"
See "Notes to Condensed Consolidated Financial Statements"
See "Notes to Condensed Consolidated Financial Statements"
See "Notes to Condensed Consolidated Financial Statements"
See "Notes to Condensed Consolidated Financial Statements"
See "Notes to Condensed Consolidated Financial Statements"
See "Notes to Condensed Consolidated Financial Statements"
See "Notes to Condensed Consolidated Financial Statements"
See "Notes to Condensed Consolidated Financial Statements"
See "Notes to Condensed Consolidated Financial Statements"
See "Notes to Condensed Consolidated Financial Statements"
See "Notes to Condensed Consolidated Financial Statements"


Pyxus International, Inc. and Subsidiaries	Pyxus International, Inc. and Subsidiaries															Pyxus International, Inc. and Subsidiaries
Condensed Consolidated Statements of Stockholders' Equity	Condensed Consolidated Statements of Stockholders' Equity															Condensed Consolidated Statements of Stockholders' Equity
(Unaudited)	(Unaudited)															(Unaudited)

		Attributable to Pyxus International, Inc.
		Attributable to Pyxus International, Inc.
		Attributable to Pyxus International, Inc.
		Attributable to Pyxus International, Inc.
						Accumulated Other Comprehensive Income (Loss)

						Accumulated Other Comprehensive Income (Loss)
						Accumulated Other Comprehensive Income (Loss)
						Accumulated Other Comprehensive Income (Loss)
(in thousands)
(in thousands)
(in thousands)	(in thousands)	Common Stock		Retained Deficit		Currency Translation Adjustment		Pensions, Net of Tax		Derivatives, Net of Tax		Noncontrolling Interests		Total Stockholders' Equity		Common Stock	Retained Deficit	Currency Translation Adjustment	Pensions, Net of Tax	Derivatives, Net of Tax	Noncontrolling Interests	Total Stockholders' Equity
Balance, March 31, 2023	Balance, March 31, 2023	$	390,290	$	(257,954)	$	(6,392)	$	8,335	$	3,572	$	3,979	$	141,830
Net income (loss)	Net income (loss)	—		804		—		—		—		(34)		770

Other comprehensive income, net of tax

Other comprehensive income, net of tax

Other comprehensive income, net of tax	Other comprehensive income, net of tax	—		—		707		—		862		—		1,569
Balance, June 30, 2023	Balance, June 30, 2023	$	390,290	$	(257,150)	$	(5,685)	$	8,335	$	4,434	$	3,945	$	144,169
Net income (loss)	Net income (loss)	—		8,095		—		—		—		(199)		7,896
Other	Other	—		—		—		—		—		493		493

Other comprehensive loss, net of tax	Other comprehensive loss, net of tax	—		—		(1,545)		—		(1,000)		—		(2,545)

Other comprehensive loss, net of tax

Other comprehensive loss, net of tax
Balance, September 30, 2023	Balance, September 30, 2023	$	390,290	$	(249,055)	$	(7,230)	$	8,335	$	3,434	$	4,239	$	150,013
Net income

Other
Other
Other
Dividends paid
Other comprehensive income (loss), net of tax
Balance, December 31, 2023


Balance, March 31, 2022

Balance, March 31, 2022

Balance, March 31, 2022	Balance, March 31, 2022	$	390,290	$	(218,813)	$	(8,873)	$	6,328	$	6,349	$	6,090	$	181,371
Net (loss) income	Net (loss) income	—		(14,663)		—		—		—		158		(14,505)
Other	Other	—		—		—		—		—		(3,052)		(3,052)
Other comprehensive income (loss), net of tax	Other comprehensive income (loss), net of tax	—		—		947		—		(1,503)		—		(556)
Balance, June 30, 2022	Balance, June 30, 2022	$	390,290	$	(233,476)	$	(7,926)	$	6,328	$	4,846	$	3,196	$	163,258
Net loss	Net loss	—		(1,537)		—		—		—		(13)		(1,550)
Other comprehensive loss, net of tax	Other comprehensive loss, net of tax	—		—		(4,801)		(1,562)		(1,768)		—		(8,131)
Balance, September 30, 2022	Balance, September 30, 2022	$	390,290	$	(235,013)	$	(12,727)	$	4,766	$	3,078	$	3,183	$	153,577
Net (loss) income

Other comprehensive income (loss), net of tax

Other comprehensive income (loss), net of tax

Other comprehensive income (loss), net of tax
Balance, December 31, 2022

See "Notes to Condensed Consolidated Financial Statements"

Pyxus International, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(Unaudited)

Pyxus International, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(Unaudited)

Pyxus International, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(Unaudited)

Six Months Ended

Nine Months Ended

(in thousands)

September 30, 2023

September 30, 2022

(in thousands)

December 31, 2023

December 31, 2022

Operating Activities:

Net income (loss)

8,666

(16,055)

Net income (loss)

Adjustments to reconcile net income (loss) to net cash used in operating activities:

Depreciation and amortization

9,319

10,284

Debt amortization/interest

5,118

10,401

Loss on foreign currency transactions

4,551

970

Asset impairment charges

—

4,035

Loss on deconsolidation/disposition of subsidiaries

—

648

Loss on deconsolidation/disposition of subsidiaries

Loss on pension settlement

—

2,588

Loss from unconsolidated affiliates, net of dividends

13,707

6,217

Income from unconsolidated affiliates, net of dividends

Changes in operating assets and liabilities, net

Trade and other receivables

(143,199)

(48,424)

Inventories and advances to tobacco suppliers

(128,596)

(146,470)

Deferred items

(4,902)

(19,089)

Recoverable income taxes

(95)

(3,481)

Payables and accrued expenses

(10,251)

(76,646)

Advances from customers

3,559

(9,238)

Prepaid expenses

(712)

2,069

Income taxes

(5,341)

(281)

Other operating assets and liabilities

1,840

6,421

Other, net

(9,084)

(10,617)

Net cash used in operating activities

(255,420)

(286,668)

Investing Activities:

Purchases of property, plant, and equipment

(9,225)

(5,426)

Proceeds from sale of property, plant, and equipment

2,822

2,114

Collections from beneficial interests in securitized trade receivables

79,296

76,209

Proceeds from settlement of debt claims from deconsolidated subsidiaries

—

2,011

Proceeds from settlement of debt claims from deconsolidated subsidiaries

Other, net

250

477

Net cash provided by investing activities

73,143

75,385

Financing Activities:

Net proceeds from short-term borrowings

192,186

176,302

Repayment of DDTL facility

—

(110,250)

Proceeds from term loan facility

—

100,000

Proceeds from revolving loan facilities

105,000

45,000

Repayment of revolving loan facilities

(130,000)

(80,000)

Debt issuance costs

(3,851)

(5,544)

Debt issuance costs

Fees paid to refinance the DDTL facility

—

(4,000)

Other, net

(67)

340

Net cash provided by financing activities

163,268

121,848

Effect of exchange rate changes on cash

(2,230)

3,894

Effect of exchange rate changes on cash

Decrease in cash, cash equivalents, and restricted cash

(21,239)

(85,541)

(Decrease) increase in cash, cash equivalents, and restricted cash

Cash and cash equivalents at beginning of period

136,733

198,777

Restricted cash at beginning of period

2,176

2,537

Cash, cash equivalents, and restricted cash at end of period

117,670

115,773

Pyxus International, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(Unaudited)

Pyxus International, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(Unaudited)

Pyxus International, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(Unaudited)

Six Months Ended

Nine Months Ended

(in thousands)

September 30, 2023

September 30, 2022

(in thousands)

December 31, 2023

December 31, 2022

Other information:

Cash paid for income taxes, net

6,604

11,235

Cash paid for income taxes related to debt exchange

12,543

—

Cash paid for interest, net

43,881

37,906

Noncash investing activities:

Noncash amounts obtained as a beneficial interest in exchange for transferring trade receivables in a securitization transaction

83,278

70,662

See "Notes to Condensed Consolidated Financial Statements"




Pyxus International, Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(in thousands, except per share data)
Note 1	Basis of Presentation and Summary of Significant Accounting Policies	10
Note 2	~~Revenue Recognition~~New Accounting Standards	10
Note 3	Revenue Recognition	11
Note 4	Restructuring and Asset Impairment Charges	11
Note 4 5	Income Taxes	1112
Note 5 6	Earnings (Loss) Per Share	1112
Note 6 7	Inventories, Net	1112
Note 7 8	Equity Method Investments	12
Note 8 9	Variable Interest Entities	1213
Note 9 10	Other Intangible Assets, Net	13
Note 101 1	Debt Arrangements	14
Note 111 2	Securitized Receivables	1718
Note 121 3	Guarantees	18
Note 131 4	Derivative Financial Instruments	1819
Note 141 5	Fair Value Measurements	19
Note 151 6	~~Contingencies~~Pension and Other ~~Information~~	19
~~Note 16~~	~~Related Party Transactions~~Postretirement Benefits	20
Note 171 7	Contingencies and Other Information	~~Segment Information~~20
Note 1 8	Related Party Transactions	21
Note 181 9	~~Subsequent Event~~Segment Information	2122

1. Basis of Presentation and Summary of Significant Accounting Policies

The accompanying condensed consolidated financial statements represent the consolidation of Pyxus International, Inc. (the "Company", "Pyxus", "we", or "us") and all companies that Pyxus directly or indirectly controls, either through majority ownership or otherwise. These condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, they do not include the information and footnotes required by U.S. GAAP for annual financial statements. In the opinion of management, the normal and recurring adjustments necessary for fair statement of financial position, results of operations, and cash flows at the dates and for the periods presented have been included. Intercompany accounts and transactions have been eliminated.

These condensed consolidated interim financial statements should be read in conjunction with the Company's consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2023 filed on June 6, 2023. Due to the seasonal nature of the Company’s business, the results of operations for a fiscal quarter are not necessarily indicative of the operating results that may be attained for other quarters or a full fiscal year.

2. New Accounting Standards

Accounting Pronouncements Not Yet Adopted

In November 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2023-07, Segment Reporting: Improvements to Reportable Segment Disclosures. This ASU amends FASB Topic 280 to permit the disclosure of multiple measures of a segment's profit or loss, and requires an entity with a single reportable segment to apply FASB Topic 280 in its entirety. In addition, this ASU requires the following new segment disclosures:

•Significant segment expenses by reportable segment if regularly provided to the Chief Operating Decision Maker ("CODM") and included within the reported measure of segment profit or loss;

•Other segment items, which represents the difference between reported segment revenues less the significant segment expenses less reported segment profit or loss; and

•Title and position of the CODM.

Disclosures required under this new ASU and the existing segment profit or loss and assets disclosures currently required annually by FASB Topic 280 are to be disclosed in interim periods. The annual disclosure requirements are effective for the Company's fiscal year ending March 31, 2025, and the interim period disclosure requirements are effective beginning April 1, 2025. Early adoption is permitted. The Company is currently evaluating the impact that this new accounting standard will have on its segment disclosures.

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes: Improvements to Income Tax Disclosures, to provide more disaggregation of income tax information mainly related to the effective tax rate reconciliation and the income taxes paid disclosure requirements. Under the new accounting rules, the tabular effective tax rate reconciliation must include specific categories with certain reconciling items based on the expected tax further disaggregated by nature and/or jurisdiction. Income taxes paid, net of refunds received, must be broken out by federal, state, and foreign taxes, and further disaggregated by individual jurisdictions based on total income taxes paid. These new annual disclosure requirements are effective for the Company's fiscal year ending March 31, 2026. Early adoption is permitted. The Company is currently evaluating the impact that this new accounting standard will have on its income tax disclosures.

3. Revenue Recognition

Product revenue is primarily from the sale of processed tobacco to customers. Processing and other revenues are mainly derived via contracts to process customer-owned green tobacco. During such processing, ownership remains with the customers. All Other revenue is primarily composed of revenue from the sale of e-liquids and non-tobacco agriculture products. The following disaggregates sales and other operating revenues by major source, with the All Other category being included for purposes of reconciliation of the respective balances below of the Leaf segment (the Company's sole reportable segment) to the condensed consolidated financial statements:


		Three Months Ended				Six Months Ended
		September 30,
		2023		2022		2023		2022
	Three Months Ended										Three Months Ended		Nine Months Ended
	December 31,										December 31,		December 31,
	2023									2023	2022	2023	2022
Leaf:	Leaf:
Product revenue
Product revenue
Product revenue	Product revenue	$	585,801	$	475,599	$	1,036,739	$	798,483
Processing and other revenues	Processing and other revenues	37,326		30,342		62,821		48,084
Total sales and other operating revenues	Total sales and other operating revenues	623,127		505,941		1,099,560		846,567
All Other:	All Other:
Total sales and other operating revenues	Total sales and other operating revenues	1,126		2,337		1,785		5,616
Total sales and other operating revenues	Total sales and other operating revenues	$	624,253	$	508,278	$	1,101,345	$	852,183
Total sales and other operating revenues
Total sales and other operating revenues

The following summarizes activity in the allowance for expected credit losses:


		Three Months Ended				Six Months Ended
		September 30,
		2023		2022		2023		2022
	Three Months Ended										Three Months Ended		Nine Months Ended
	December 31,										December 31,		December 31,
	2023									2023	2022	2023	2022
Balance, beginning of period	Balance, beginning of period	$	(24,440)	$	(23,330)	$	(24,730)	$	(24,541)
Additions	Additions	(238)		(860)		(558)		(1,025)
Write-offs and other adjustments	Write-offs and other adjustments	305		492		915		1,868
Balance, end of period	Balance, end of period	(24,373)		(23,698)		(24,373)		(23,698)
Trade receivables	Trade receivables	258,052		228,722		258,052		228,722
Trade receivables, net	Trade receivables, net	$	233,679	$	205,024	$	233,679	$	205,024

3.4. Restructuring and Asset Impairment Charges

The Company continued its focus on ~~cost saving~~cost-saving initiatives. The employee separation and asset impairment charges for the periods ended ~~September 30,~~December 31, 2023 were primarily related to changes in the corporate organizational structure and the continued restructuring of certain leaf operations. The employee separation and asset impairment charges for the periods ended ~~September 30,~~December 31, 2022 were primarily related to the restructuring of certain non-leaf agriculture operations. The following summarizes the Company's restructuring and asset impairment charges:


		Three Months Ended				Six Months Ended
		September 30,
		2023		2022		2023		2022
	Three Months Ended										Three Months Ended		Nine Months Ended
	December 31,										December 31,		December 31,
	2023									2023	2022	2023	2022
Employee separation charges	Employee separation charges	$	1,254	$	10	$	1,294	$	310
Asset impairment and other non-cash charges	Asset impairment and other non-cash charges	—		4,035		—		4,035
Restructuring and asset impairment charges	Restructuring and asset impairment charges	$	1,254	$	4,045	$	1,294	$	4,345

5. Income Taxes

For each period presented, the Company's quarterly provision for income taxes is not calculated using the annual effective tax rate method ("AETR method"), which applies an estimated annual effective tax rate to pre-tax income or loss. As of the end of the current period, market specific factors coupled with tax rate sensitivity caused the AETR method to produce an unreliable estimate of the Company’s annual effective tax rate; therefore, the Company recorded its interim income tax provision using the discrete method, as allowed under FASB ASC 740-270, Income Taxes - Interim Reporting. Using the discrete method, the Company determined income tax expense as if each of the ~~six-month~~nine-month interim periods reported were an annual period.

The effective tax rate for the ~~six~~nine months ended ~~September 30,~~December 31, 2023 and 2022 was ~~53.9%~~72.2% and ~~8.9%~~(119.9)%, respectively. For the ~~six~~nine months ended ~~September 30,~~December 31, 2023, the difference between the Company’s effective rate and the U.S. statutory rate of 21.0% is primarily due to ~~a $6,658 increase~~increases in the Company's deferred tax valuation allowances, liability for unrecognized tax benefits, ~~in Africa, the impact of changes in valuation allowance for non-deductible interest, U.S. taxation of foreign earnings,~~ and variations in the jurisdictional mix of earnings.

5.6. Earnings (Loss) Per Share

The following summarizes the computation of ~~income~~earnings (loss) per share:


		Three Months Ended				Six Months Ended
		September 30,
		2023		2022		2023		2022
	Three Months Ended										Three Months Ended		Nine Months Ended
	December 31,										December 31,		December 31,
	2023									2023	2022	2023	2022
Basic and diluted earnings (loss) per share:	Basic and diluted earnings (loss) per share:
Net income (loss) attributable to Pyxus International, Inc.	Net income (loss) attributable to Pyxus International, Inc.	$	8,095	$	(1,537)	$	8,899	$	(16,200)
Net income (loss) attributable to Pyxus International, Inc.
Net income (loss) attributable to Pyxus International, Inc.
Shares:	Shares:
Weighted average number of shares outstanding
Weighted average number of shares outstanding
Weighted average number of shares outstanding	Weighted average number of shares outstanding	25,000		25,000		25,000		25,000
Basic and diluted earnings (loss) per share	Basic and diluted earnings (loss) per share	$	0.32	$	(0.06)	$	0.36	$	(0.65)

6.7. Inventories, Net

The following summarizes the composition of inventories, net:


		September 30, 2023		September 30, 2022		March 31, 2023
	December 31, 2023							December 31, 2023	December 31, 2022	March 31, 2023
Processed tobacco	Processed tobacco	$	646,757	$	712,078	$	498,398
Unprocessed tobacco	Unprocessed tobacco	188,489		131,867		231,651
Other tobacco related	Other tobacco related	28,814		34,577		39,670
All Other	All Other	13,094		11,575		5,352
Total	Total	$	877,154	$	890,097	$	775,071

7.8. Equity Method Investments

The following summarizes the Company's equity method investments as of ~~September 30,~~December 31, 2023:

Investee Name

Location

Primary Purpose

Ownership Percentage

Basis Difference

Investee Name

Location

Primary Purpose

Ownership Percentage

Basis Difference

Adams International Ltd.

Thailand

Purchase and process tobacco

49%

(4,526)

Alliance One Industries India Private Ltd.

India

Purchase and process tobacco

49%

(5,770)

China Brasil Tabaco Exportadora SA

Brazil

Purchase and process tobacco

49%

43,599

Oryantal Tütün Paketleme Sanayi ve Ticaret A.Ş.

Turkey

Process tobacco

50%

(416)

Purilum, LLC

U.S.

Produce flavor formulations and consumable e-liquids

50%

4,589

Siam Tobacco Export Company

Thailand

Purchase and process tobacco

49%

(6,098)

The following summarizes financial information for these equity method investments:


		Three Months Ended				Six Months Ended
		September 30,
		2023		2022		2023		2022
	Three Months Ended										Three Months Ended		Nine Months Ended
	December 31,										December 31,		December 31,
	2023									2023	2022	2023	2022
Operations statement:	Operations statement:
Sales
Sales
Sales	Sales	$	81,455	$	62,275	$	126,287	$	131,657
Gross profit	Gross profit	12,173		5,766		19,359		19,855
Net income	Net income	5,010		3,913		1,156		12,243
Company's dividends received	Company's dividends received	13,660		1		13,660		11,523


		September 30, 2023		September 30, 2022		March 31, 2023
	December 31, 2023							December 31, 2023	December 31, 2022	March 31, 2023
Balance sheet:	Balance sheet:
Current assets
Current assets
Current assets	Current assets	$	453,711	$	414,911	$	419,229
Property, plant, and equipment and other assets	Property, plant, and equipment and other assets	48,315		38,113		48,174
Current liabilities	Current liabilities	386,646		336,815		323,899
Long-term obligations and other liabilities	Long-term obligations and other liabilities	2,487		2,463		3,887

8.9. Variable Interest Entities

The Company holds variable interests in multiple entities that primarily procure or process inventory or are securitization entities. These variable interests relate to equity investments, receivables, guarantees, and securitized receivables. The following summarizes the Company's financial relationships with its unconsolidated variable interest entities:


		September 30, 2023		September 30, 2022		March 31, 2023
		December 31, 2023
		December 31, 2023
		December 31, 2023						December 31, 2022	March 31, 2023
Investments in variable interest entities	Investments in variable interest entities	$	80,067	$	81,988	$	93,754
Receivables with variable interest entities	Receivables with variable interest entities	12,754		1,882		2,617
Guaranteed amounts to variable interest entities (not to exceed)	Guaranteed amounts to variable interest entities (not to exceed)	61,132		64,448		68,265

9.10. Other Intangible Assets, Net

The following summarizes the changes in the Company's other intangible assets, net:


		Six Months Ended September 30, 2023
		Nine Months Ended December 31, 2023
		Nine Months Ended December 31, 2023
		Nine Months Ended December 31, 2023
		Weighted Average Remaining Useful Life	Beginning Carrying Amount, Net		Amortization Expense		Ending Intangible Assets, Net		Weighted Average Remaining Useful Life	Beginning Carrying Amount, Net	Amortization Expense	Ending Intangible Assets, Net
Intangibles subject to amortization:	Intangibles subject to amortization:
Customer relationships
Customer relationships
Customer relationships	Customer relationships	8.9 years	$	20,482	$	(1,088)	$	19,394
Technology	Technology	4.8 years	8,875		(829)		8,046
Trade names	Trade names	10.9 years	9,215		(404)		8,811
Total	Total		$	38,572	$	(2,321)	$	36,251


	Year Ended March 31, 2023
	Weighted Average Remaining Useful Life	Beginning Carrying Amount, Net		Amortization Expense		Ending Intangible Assets, Net
Intangibles subject to amortization:
Customer relationships	9.4 years	$	23,568	$	(3,086)	$	20,482
Technology	5.2 years	11,471		(2,596)		8,875
Trade names	11.4 years	10,022		(807)		9,215
Total		$	45,061	$	(6,489)	$	38,572

~~10.~~11. Debt Arrangements

The following summarizes debt and notes payable:


					September 30,				March 31,
					December 31,
					December 31,
					December 31,
(in thousands)
(in thousands)
(in thousands)	(in thousands)	Interest Rate			2023		2022		2023
Senior secured credit facilities:	Senior secured credit facilities:
Senior secured credit facilities:
Senior secured credit facilities:
ABL Credit Facility	ABL Credit Facility	7.6	%	(1)	$	—	$	55,000	$	25,000
ABL Credit Facility
ABL Credit Facility
Term Loan Facility (2)
Term Loan Facility (2)
Term Loan Facility (2)	Term Loan Facility (2)	12.3	%	(1)	—		96,464		—

Senior secured notes:	Senior secured notes:

Senior secured notes:

Senior secured notes:
10.0% Notes Due 2024 (3)	10.0% Notes Due 2024 (3)	10.0	%	(1)	20,085		272,621		19,931
10.0% Notes Due 2024 (3)
10.0% Notes Due 2024 (3)
8.5% Notes Due 2027 (4)
8.5% Notes Due 2027 (4)
8.5% Notes Due 2027 (4)	8.5% Notes Due 2027 (4)	8.6	%	(1)	254,076		—		253,483

Senior secured term loans:	Senior secured term loans:

Senior secured term loans:

Senior secured term loans:
Intabex Term Loans (5)
Intabex Term Loans (5)
Intabex Term Loans (5)	Intabex Term Loans (5)	13.3	%	(1)	186,424		$	—	186,194
Pyxus Term Loans (6)	Pyxus Term Loans (6)	13.3	%	(1)	133,170		$	—	133,393
Pyxus Term Loans (6)
Pyxus Term Loans (6)
Exit Facility Loans (7)
Exit Facility Loans (7)
Exit Facility Loans (7)	Exit Facility Loans (7)	12.0	%	(1)	—		$	221,606	—

Other Debt:	Other Debt:

Other Debt:

Other Debt:
Other long-term debt
Other long-term debt
Other long-term debt	Other long-term debt	8.2	%	(1)	436		574		504
Notes payable (8)	Notes payable (8)	8.5	%	(1)	570,036		548,490		382,544
Notes payable (8)
Notes payable (8)
Total debt
Total debt
Total debt	Total debt				$	1,164,227	$	1,194,755	$	1,001,049

Short-term (8)	Short-term (8)				$	570,036	$	548,490	$	382,544

Short-term (8)

Short-term (8)
Long-term:
Long-term:
Long-term:	Long-term:
Current portion of long-term debt	Current portion of long-term debt				$	20,232	$	140	$	75
Current portion of long-term debt
Current portion of long-term debt
Long-term debt	Long-term debt				573,959		646,125		618,430
Long-term debt
Long-term debt
Total
Total
Total	Total				$	594,191	$	646,265	$	618,505

Letters of credit	Letters of credit				$	6,783	$	14,292	$	11,684

(1) Weighted average rate for the trailing twelve months ended September 30, 2023 or, for indebtedness outstanding only during a portion of such twelve-month period, for the portion of such period that such indebtedness was outstanding.
(2) The amount outstanding at September 30, 2022 is net of original issue discount of $3,536. This Term Loan Facility was established through the refinancing of the DDTL Facility on July 28, 2022, which included a partial principal payment of $9,000 and an exit fee payment of $5,250. Subsequent to this refinancing, on February 6, 2023, the Term Loan Facility was exchanged for $102,000 (inclusive of a $2,000 exit fee) of Intabex Term Loans.
(3) On February 6, 2023, $260,452 of the 10.0% Notes due 2024 were exchanged for 8.5% Notes due 2027. The remaining 10.0% Notes due 2024 outstanding of $20,085 is net of a debt discount of $306, and are reported in the current portion of long-term debt. Total repayment at maturity is $20,391.
(4) Balance of $254,076 is net of a debt discount of $6,377. Total repayment at maturity is $260,452.
(5) Balance of $186,424 is net of a debt discount of $2,609. Total repayment at maturity is $189,033, which includes a $2,000 exit fee payable upon repayment.
(6) Balance of $133,170 is net of a debt premium of $2,620. Total repayment at maturity is $130,550.
Letters of credit

Letters of credit

(1) Weighted average rate for the trailing twelve months ended December 31, 2023 or, for indebtedness outstanding only during a portion of such twelve-month period, for the portion of such period that such indebtedness was outstanding.

(1) Weighted average rate for the trailing twelve months ended December 31, 2023 or, for indebtedness outstanding only during a portion of such twelve-month period, for the portion of such period that such indebtedness was outstanding.

(1) Weighted average rate for the trailing twelve months ended December 31, 2023 or, for indebtedness outstanding only during a portion of such twelve-month period, for the portion of such period that such indebtedness was outstanding.
(2) The amount outstanding at December 31, 2022 is net of original issue discount of $2,823. This Term Loan Facility was established through the refinancing of the DDTL Facility on July 28, 2022, which included a partial principal payment of $9,000 and an exit fee payment of $5,250. Subsequent to this refinancing, on February 6, 2023, the Term Loan Facility was exchanged for $102,000 (inclusive of a $2,000 exit fee) of Intabex Term Loans.
(2) The amount outstanding at December 31, 2022 is net of original issue discount of $2,823. This Term Loan Facility was established through the refinancing of the DDTL Facility on July 28, 2022, which included a partial principal payment of $9,000 and an exit fee payment of $5,250. Subsequent to this refinancing, on February 6, 2023, the Term Loan Facility was exchanged for $102,000 (inclusive of a $2,000 exit fee) of Intabex Term Loans.
(2) The amount outstanding at December 31, 2022 is net of original issue discount of $2,823. This Term Loan Facility was established through the refinancing of the DDTL Facility on July 28, 2022, which included a partial principal payment of $9,000 and an exit fee payment of $5,250. Subsequent to this refinancing, on February 6, 2023, the Term Loan Facility was exchanged for $102,000 (inclusive of a $2,000 exit fee) of Intabex Term Loans.
(3) On February 6, 2023, $260,452 of the 10.0% Notes due 2024 were exchanged for 8.5% Notes due 2027. The remaining 10.0% Notes due 2024 outstanding of $20,169 is net of a debt discount of $222, and are reported in the current portion of long-term debt. Total repayment at maturity is $20,391.
(3) On February 6, 2023, $260,452 of the 10.0% Notes due 2024 were exchanged for 8.5% Notes due 2027. The remaining 10.0% Notes due 2024 outstanding of $20,169 is net of a debt discount of $222, and are reported in the current portion of long-term debt. Total repayment at maturity is $20,391.
(3) On February 6, 2023, $260,452 of the 10.0% Notes due 2024 were exchanged for 8.5% Notes due 2027. The remaining 10.0% Notes due 2024 outstanding of $20,169 is net of a debt discount of $222, and are reported in the current portion of long-term debt. Total repayment at maturity is $20,391.
(4) Balance of $254,367 is net of a debt discount of $6,085. Total repayment at maturity is $260,452.
(4) Balance of $254,367 is net of a debt discount of $6,085. Total repayment at maturity is $260,452.
(4) Balance of $254,367 is net of a debt discount of $6,085. Total repayment at maturity is $260,452.
(5) Balance of $186,546 is net of a debt discount of $2,487. Total repayment at maturity is $189,033, which includes a $2,000 exit fee payable upon repayment.
(5) Balance of $186,546 is net of a debt discount of $2,487. Total repayment at maturity is $189,033, which includes a $2,000 exit fee payable upon repayment.
(5) Balance of $186,546 is net of a debt discount of $2,487. Total repayment at maturity is $189,033, which includes a $2,000 exit fee payable upon repayment.
(6) Balance of $133,053 is net of a debt premium of $2,503. Total repayment at maturity is $130,550.
(6) Balance of $133,053 is net of a debt premium of $2,503. Total repayment at maturity is $130,550.
(6) Balance of $133,053 is net of a debt premium of $2,503. Total repayment at maturity is $130,550.
(7) On February 6, 2023, $189,033, representing 40.0% of the Exit Facility Loans, were exchanged for Intabex Term Loans, and $130,550, representing the remaining 60.0% of the Exit Facility Loans, were exchanged for Pyxus Term Loans.
(7) On February 6, 2023, $189,033, representing 40.0% of the Exit Facility Loans, were exchanged for Intabex Term Loans, and $130,550, representing the remaining 60.0% of the Exit Facility Loans, were exchanged for Pyxus Term Loans.
(7) On February 6, 2023, $189,033, representing 40.0% of the Exit Facility Loans, were exchanged for Intabex Term Loans, and $130,550, representing the remaining 60.0% of the Exit Facility Loans, were exchanged for Pyxus Term Loans.	(7) On February 6, 2023, $189,033, representing 40.0% of the Exit Facility Loans, were exchanged for Intabex Term Loans, and $130,550, representing the remaining 60.0% of the Exit Facility Loans, were exchanged for Pyxus Term Loans.
(8) Primarily foreign seasonal lines of credit.
(8) Primarily foreign seasonal lines of credit.
(8) Primarily foreign seasonal lines of credit.

Outstanding Senior Secured Debt

ABL Credit Facility

On February 8, 2022, the Company’s wholly owned subsidiary, Pyxus Holdings, Inc. ("Pyxus Holdings"), certain subsidiaries of Pyxus Holdings (together with Pyxus Holdings, the "Borrowers"), and the Company and its wholly owned subsidiary, Pyxus Parent, Inc. ("Pyxus Parent"), as parent guarantors, entered into an ABL Credit Agreement (as amended, ~~on May 23, 2023,~~ the "ABL Credit Agreement"), dated as of February 8, 2022, by and among Pyxus Holdings, as Borrower Agent, the Borrowers and parent guarantors party thereto, the lenders party thereto, and PNC Bank, National Association, as Administrative Agent and Collateral Agent, to establish an asset-based revolving credit facility (the "ABL Credit Facility"), the proceeds of which may be used to refinance existing senior bank debt, pay fees and expenses related to the ABL Credit Facility, partially fund capital expenditures, and provide for the ongoing working capital needs of the Borrowers. A detailed description of the ABL Credit Agreement is included in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2023. The ABL Credit Agreement was amended on May 23, 2023 to extend the maturity of the ABL Credit Facility to February 8, 2027. The ABL Credit Agreement was amended on October 24, 2023 to, among other things:

•increase the aggregate amount of the revolving loan commitments under the ABL Credit Facility to $120,000;

•adjust the fee payable on unused borrowing availability under the ABL Credit Facility from a rate of 0.375% per annum to a rate of (i) 0.25% per annum if the outstanding borrowings equal or exceed $60,000 and (ii) 0.375% per annum if the outstanding borrowings are less than $60,000;

•adjust the covenant restricting the prepayment of the New Term Loans, the 2024 Notes and the 2027 Notes (as such terms are defined below) to permit prepayments, subject to an aggregate limit of $100,000, based on excess borrowing availability under the ABL Credit Facility, after giving pro forma effect to the prepayment, being at least equal to a specified level, with an increased amount being permitted upon pro forma satisfaction of a minimum fixed charge coverage ratio;

•adjust the events triggering application of the cash dominion provisions of the ABL Credit Agreement, in the absence of an event of default, to be if (i) excess borrowing availability under the ABL Credit Facility (based on the lesser of the commitments thereunder and the borrowing base) falls below the greater of $10,000 or 10% of the lesser of total commitments under the ABL Credit Facility at such time and the borrowing base at such time or (ii) Domestic Availability (as defined in the ABL Credit Agreement) being less than the greater of $20,000 or 20% of the lesser of total commitments under the ABL Credit Facility at such time and the borrowing base at such time, with similar adjustments to the events triggering termination of the application of the cash dominion provisions.

The ABL Credit Facility may be used for revolving credit loans and letters of credit from time to time up to an initial maximum principal amount of $~~100,000,~~120,000, subject to the limitations described in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2023. The ABL Credit Facility includes a $20,000 uncommitted accordion feature that permits Pyxus Holdings, under certain conditions, to solicit the lenders under the ABL Credit Facility to provide additional revolving loan commitments to increase the aggregate amount of the revolving loan commitments under the ABL Credit Facility not to exceed a maximum principal amount of $120,000. The ABL Credit Facility matures, subject to extension on terms and conditions set forth in the ABL Credit Agreement, on February 8, 2027. A detailed description of the ABL Credit Agreement is included in the Company's Annual Report on Form 10-K for the fiscal year ended March$140,000. At December 31, ~~2023. At September 30,~~ 2023, the Borrowers and the parent guarantors under the ABL Credit Agreement were in compliance with the covenants under the ABL Credit Agreement.

Intabex Term Loans

Pursuant to (i) an exchange offer (the "DDTL Facility Exchange") made to, and accepted by, holders of 100.0% of the outstanding term loans (the "DDTL Term Loans") under the Amended and Restated Term Loan Credit Agreement, effectuated pursuant to that certain Amendment and Restatement Agreement, dated as of June 2, 2022 (the "DDTL Credit Agreement"), by and among Intabex Netherlands B.V., as borrower ("Intabex"), the guarantors party thereto, the administrative agent and collateral agent thereunder, and the several lenders from time to time party thereto and (ii) an exchange offer (the "Exit Facility Exchange") made to, and accepted by, holders of 100.0% of the outstanding term loans (the "Exit Term Loans") under the Exit Term Loan Credit Agreement, dated as of August 24, 2020 (the "Exit Term Loan Credit Agreement"), by and among Pyxus Holdings, as borrower, the guarantors party thereto, the administrative agent and collateral agent thereunder, and the several lenders from time to time party thereto, on February 6, 2023, Pyxus Holdings entered into the Intabex Term Loan Credit Agreement, dated as of February 6, 2023 (the "Intabex Term Loan Credit Agreement"), by and among, Pyxus Holdings, the guarantors party thereto, the lenders party thereto and Alter Domus (US) LLC ("Alter Domus"), as administrative agent and senior collateral agent. The Intabex Term Loan Credit Agreement established a term loan credit facility in an aggregate principal amount of approximately $189,033 (the "Intabex Credit Facility"), under which term loans in the full aggregate principal amount of the Intabex Credit Facility (the "Intabex Term Loans") were deemed made in exchange for (i) $100,000 principal amount of the DDTL Term Loans, plus an additional $2,000 on account of the exit fee payable under the DDTL Credit Agreement and (ii) approximately $87,033 principal amount of Exit Term Loans, representing 40.0% of the outstanding principal amount thereof (including the applicable accrued and unpaid PIK interest thereon). The Intabex Term Loans bear interest, at Pyxus Holdings’ option, at either (i) a term SOFR rate (subject to a floor of 1.5%) plus 8.0% per annum or (ii) an alternate base rate plus 7.0% per annum. The Intabex Term Loans are stated to mature on December 31, 2027. A detailed description of the Intabex Term Loan Credit Agreement is included in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2023. At ~~September 30,~~December 31, 2023, Pyxus Holdings and the guarantors under the Intabex Term Loan Credit Agreement were in compliance with all covenants under the Intabex Term Loan Credit Agreement.

Pyxus Term Loans

Pursuant to the Exit Facility Exchange, on February 6, 2023, Pyxus Holdings entered into the Pyxus Term Loan Credit Agreement, dated as of February 6, 2023 (the "Pyxus Term Loan Credit Agreement"), by and among, Pyxus Holdings, the guarantors party thereto, the lenders party thereto and Alter Domus, as administrative agent and senior collateral agent, to establish a term loan credit facility in an aggregate principal amount of approximately $130,550 (the "Pyxus Credit Facility"), under which term loans in the full aggregate principal amount of the Pyxus Credit Facility (the "Pyxus Term Loans" and, together with the Intabex Term Loans, the "New Term Loans") were deemed made in exchange for 60.0% of the outstanding principal amount of Exit Term Loans (including the applicable accrued and unpaid PIK interest thereon). The Pyxus Term Loans bear interest, at Pyxus Holdings’ option, at either (i) a term SOFR rate (subject to a floor of 1.5%) plus 8.0% per annum or (ii) an alternate base rate plus 7.0% per annum. The Pyxus Term Loans are stated to mature on December 31, 2027. A detailed description of the Pyxus Term Loan Credit Agreement is included in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2023. At ~~September 30,~~December 31, 2023, Pyxus Holdings and the guarantors under the Pyxus Term Loan Credit Agreement were in compliance with all covenants under the Pyxus Term Loan Credit Agreement.

8.50% Senior Secured Notes due 2027

Pursuant to an exchange offer (the "Notes Exchange" and, together with the DDTL Facility Exchange and the Exit Facility Exchange, the "Debt Exchange Transactions") made by Pyxus Holdings and accepted by holders of approximately 92.7% of the aggregate principal amount of the outstanding 10.0% Senior Secured First Lien Notes due 2024 issued by Pyxus Holdings (the "2024 Notes") pursuant to that certain Indenture, dated as of August 24, 2020 (the "2024 Notes Indenture"), by and among Pyxus Holdings, the guarantors party thereto and the trustee, collateral agent, registrar and paying agent thereunder, on

February 6, 2023, Pyxus Holdings issued approximately $260,452 in aggregate principal amount of 8.5% Senior Secured Notes due December 31, 2027 (the "2027 Notes" and, together with the New Term Loans, the "New Secured Debt") to the exchanging holders of the 2024 Notes for an equal principal amount of 2024 Notes. The 2027 Notes were issued pursuant to the Indenture, dated as of February 6, 2023 (the "2027 Notes Indenture"), among Pyxus Holdings, the guarantors party thereto, and Wilmington Trust, National Association, as trustee, and Alter Domus, as collateral agent. The 2027 Notes bear interest at a rate of 8.5% per annum, which interest is computed on the basis of a 360-day year comprised of twelve 30-day months. The 2027 Notes are stated to mature on December 31, 2027. A detailed description of the 2027 Notes and the 2027 Notes Indenture is included in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2023. At ~~September 30,~~December 31, 2023, Pyxus Holdings and the guarantors of the 2027 Notes were in compliance with all covenants under the 2027 Notes Indenture.

Refinanced Senior Secured Debt

DDTL Facility

On April 23, 2021 (the “DDTL Closing Date”), Intabex entered into a Term Loan Credit Agreement (as amended on May 21, 2021, the "Initial DDTL Facility Credit Agreement"), dated as of April 23, 2021, by and among (i) Intabex, as borrower, (ii) the Company, Pyxus Parent, Pyxus Holdings, Alliance One International, LLC, Alliance One International Holdings, Ltd, as guarantors (collectively, the "Parent Guarantors"), (iii) the lenders thereto, which included certain funds managed by Glendon Capital Management, L.P., Monarch Alternative Capital LP, and Owl Creek Asset Management, L.P. (collectively and, together other lenders that became parties thereto as lenders, the "DDTL Facility Lenders"), and (iv) Alter Domus, as administrative agent and collateral agent. The Initial DDTL Facility Credit Agreement established a $120,000 delayed-draw term loan credit facility (the "Initial DDTL Facility") under which the full amount was drawn (the "Initial DDTL Loans") by March 31, 2022. The obligations of Intabex under the Initial DDTL Facility Credit Agreement (and certain related obligations) were (a) guaranteed by the Parent Guarantors and Alliance One International Tabak B.V., an indirect subsidiary of the Company, and each of the Company’s domestic and foreign subsidiaries that was or became a guarantor of borrowings under the Exit Term Loan Credit Agreement and (b) was secured by the pledge of all of the outstanding equity interests of (i) Alliance One Brasil Exportadora de Tabacos Ltda. ("AO Brazil"), which principally operates the Company’s leaf tobacco operations in Brazil, and (ii) Alliance One International Tabak B.V., which owns a 0.001% interest of AO Brazil. The Initial DDTL Credit Facility Agreement was amended and restated by the DDTL Credit Agreement, which established a $100,000 term loan credit facility (the "DDTL Term Loan Facility") and required that Intabex use the net proceeds of the DDTL Term Loans made thereunder and other funds to repay in full its obligations under the Initial DDTL Facility Credit Agreement, including the outstanding principal of, and accrued and unpaid interest on, borrowings under the Initial DDTL Facility and the payment of fees and expenses incurred in connection with repaying such borrowings and incurring the DDTL Term Loans under the DDTL Credit Agreement. The DDTL Term Loans were exchanged upon consummation of the DDTL Facility Exchange on February 6, 2023.

Exit Term Loan Credit Facility

On August 24, 2020, pursuant to the Exit Term Loan Credit Agreement, Pyxus Holdings became obligated with respect to the Exit Term Loans in an aggregate principal amount of approximately $213,418. Pyxus Holdings’ obligations under the Exit Term Loan Credit Agreement (and certain related obligations) were (a) guaranteed by Pyxus Parent, Inc. and the Company, all of Pyxus Holdings’ material domestic subsidiaries and certain of Pyxus Holdings’ foreign subsidiaries, and each of Pyxus Holdings’ material domestic subsidiaries was required to guarantee the Exit Term Loan Credit Agreement on a senior secured basis and (b) secured by specified collateral owned by Pyxus Holdings and such guarantors. The Exit Term Loans were exchanged upon consummation of the DDTL Facility Exchange and the Exit Facility Exchange on February 6, 2023.

Related Party Transactions

The Company, Pyxus Parent and Pyxus Holdings (collectively, the "Holding Companies") entered into a Support and Exchange Agreement, effective as of December 27, 2022 (as amended, including by joinders thereto, the "Support Agreement"), with a group of creditors, including Glendon Capital Management LP, Monarch Alternative Capital LP, Nut Tree Capital Management, L.P., Intermarket Corporation and Owl Creek Asset Management, L.P. on behalf of certain funds managed by them and/or certain of their advisory clients, as applicable (collectively, the "Supporting Holders"), holding in aggregate:

•approximately 99.7% of the DDTL Term Loans outstanding under the DDTL Credit Agreement;

•approximately 68.1% of the Exit Term Loans outstanding under the Exit Term Loan Credit Agreement; and

•approximately 64.1% of the 2024 Notes outstanding under the 2024 Notes Indenture.

Pursuant to the Support Agreement, the Supporting Holders agreed to participate in the Debt Exchange Transactions. Based on a Schedule 13D/A filed with the SEC on January 4, 2023 by Glendon Capital Management, L.P. (the "Glendon Investor"), Glendon Opportunities Fund, L.P. and Glendon Opportunities Fund II, L.P., Glendon Capital Management, L.P. reported beneficial ownership of 7,939 shares of the Company’s common stock, representing approximately 31.8% of the outstanding shares of the Company’s common stock. Based on a Schedule 13D/A filed with the SEC on January 23, 2023, by Monarch Alternative Capital LP (the "Monarch Investor"), MDRA GP LP and Monarch GP LLC, Monarch Alternative Capital LP reported beneficial ownership of 6,140 shares of the Company’s common stock, representing approximately 24.6% of the outstanding shares of the Company’s common stock. Based on a Schedule 13G/A filed with the SEC on February 10, 2022 by Owl Creek Asset Management, L.P. and Jeffrey A. Altman, Owl Creek Asset Management, L.P. is the investment manager of

certain funds and reported beneficial ownership of 2,405 shares of the Company’s common stock on December 31, 2021, representing approximately 9.6% of the outstanding shares of the Company’s common stock. A representative of the Glendon Investor and a representative of the Monarch Investor served as directors of Pyxus at the time the Company and its applicable subsidiaries entered into the Initial DDTL Credit Facility Agreement, the amendments thereto (including the DDTL Credit Agreement) and the Support Agreement, effected borrowings under the Initial DDTL Credit Facility Agreement and the DDTL Credit Agreement and commenced the Debt Exchange Transactions. The Initial DDTL Credit Facility Agreement and the amendments thereto (including the DDTL Credit Agreement), any and all borrowings thereunder, the related guaranty transactions, the Support Agreement, and the Debt Exchange Transactions, including the Intabex Term Loan Credit Agreement, the Intabex Term Loans, the Pyxus Term Loan Credit Agreement, the Pyxus Term Loans, the 2027 Notes and the 2027 Notes Indenture were approved, and determined to be on terms and conditions at least as favorable to the Company and its subsidiaries as could reasonably have been obtained in a comparable arm’s-length transaction with an unaffiliated party, by a majority of the disinterested members of the Board of Directors of Pyxus.

Other Outstanding Debt

2024 Notes

In conjunction with the Notes Exchange, Pyxus Holdings received consents from requisite holders of 2024 Notes to amend the 2024 Notes Indenture, the 2024 Notes and the related intercreditor and security documents to, among other things, (i) eliminate most of the restrictive covenants and certain of the affirmative covenants in the 2024 Notes Indenture, (ii) eliminate the change of control repurchase obligation in the 2024 Notes Indenture, (iii) subordinate the 2024 Notes in right of payment to existing and future senior indebtedness (including the New Secured Debt), (iv) eliminate certain events of default and (v) release all of the collateral securing the 2024 Notes. On February 6, 2023, the relevant parties to the 2024 Notes Indenture entered into the Second Supplemental Indenture, dated as of February 6, 2023 (the "2024 Notes Supplemental Indenture"), to the 2024 Notes Indenture, pursuant to which the 2024 Notes Indenture, the 2024 Notes and the related intercreditor and security documents were amended to effect these changes. The 2024 Notes bear interest at a rate of 10.0% per year, payable semi-annually in arrears in cash on February 15 and August 15 of each year. The 2024 Notes are stated to mature on August 24, 2024. At ~~September 30,~~December 31, 2023, Pyxus Holdings and the guarantors of the 2024 Notes were in compliance with all covenants under the 2024 Notes Indenture, as amended by the 2024 Notes Supplemental Indenture.

Foreign Seasonal Lines of Credit

Excluding ~~all~~ long-term credit agreements, the Company typically finances its foreign operations with uncommitted short-term seasonal lines of credit arrangements with a number of banks. These operating lines are generally seasonal in nature, typically extending for a term of 180 days to 365 days corresponding to the tobacco crop cycle in that location. These facilities are typically uncommitted in that the lenders have the unilateral right to cease making loans and demand repayment of loans at any time or at specified dates. These loans are generally renewed at the outset of each tobacco season. Certain of the foreign seasonal lines of credit are secured by trade receivables and inventories as collateral and are guaranteed by the Company and certain of its subsidiaries. As of ~~September 30,~~December 31, 2023, the total borrowing capacity under individual foreign seasonal lines of credit range up to ~~$159,394.~~$160,416. As of ~~September 30,~~December 31, 2023, the aggregate amount available for borrowing under the seasonal lines of credit was ~~$130,214.~~$250,164. At ~~September 30,~~December 31, 2023, the Company was permitted to borrow under foreign seasonal lines of credit up to a total $~~663,326~~700,260, subject to limitations under the ABL Credit Agreement and the agreements governing the New Secured Debt. At ~~September 30,~~December 31, 2023, $~~904~~976 of cash was held on deposit as a compensating balance. At ~~September 30,~~December 31, 2023, the Company, and its subsidiaries, were in compliance with the covenants associated with its short-term seasonal lines of credit.

~~11.~~

12. Securitized Receivables

The Company sells trade receivables to unaffiliated financial institutions under four accounts receivable securitization facilities, two of which are subject to annual renewal. Under the first facility, the Company continuously sells a designated pool of trade receivables to a special purpose entity, which sells 100% of the receivables to an unaffiliated financial institution. As of ~~September 30,~~December 31, 2023, the investment limit of this facility was $100,000 of trade receivables. For the other facilities, the Company offers trade receivables for sale to an unaffiliated financial institution, which are then subject to acceptance by the unaffiliated financial institution. As of ~~September 30,~~December 31, 2023, the investment limit under the second facility was $110,000 of trade receivables. As of ~~September 30,~~December 31, 2023, the investment limit under the third and fourth facilities were variable based on qualifying sales. As the servicer of the first and second facilities, the Company may receive funds that are due to the unaffiliated financial institutions, which are net settled on the next settlement date. As of ~~September 30,~~December 31, 2023 and 2022, and March 31, 2023, trade receivables, net in the condensed consolidated balance sheets has been reduced by ~~$10,014, $5,108,~~$5,813, $12,280, and $3,193 as a result of the net settlement, respectively. Refer to "Note ~~14.~~1 5 . Fair Value Measurements" for additional information.

The following summarizes the Company's accounts receivable outstanding in the securitization facilities, which represents trade receivables sold into the program that have not been collected from the customer, and related beneficial interests, which represents the Company's residual interest in receivables sold that have not been collected from the customer:


	December 31, 2023							December 31, 2023	December 31, 2022	March 31, 2023
		September 30, 2023		September 30, 2022		March 31, 2023

Receivables outstanding in facility
Receivables outstanding in facility
Receivables outstanding in facility	Receivables outstanding in facility	$	177,932	$	149,523	$	173,979
Beneficial interests	Beneficial interests	24,393		22,842		19,522

Cash proceeds from the sale of trade receivables is comprised of a combination of cash and a deferred purchase price receivable. Deferred purchase price receivable is realized after the collection of the underlying trade receivables sold by the purchasers. The following summarizes the Company's cash purchase price and deferred purchase price:


		Six Months Ended
		September 30,
		2023		2022
	Nine Months Ended						Nine Months Ended
	December 31,						December 31,
	2023					2023	2022
Cash proceeds:	Cash proceeds:
Cash purchase price
Cash purchase price
Cash purchase price	Cash purchase price	$	344,823	$	320,256
Deferred purchase price	Deferred purchase price	79,296		76,209

~~12.~~13. Guarantees

In certain markets, the Company guarantees bank loans for suppliers to finance their crops. The Company also guarantees bank loans of certain unconsolidated subsidiaries. The following summarizes amounts guaranteed and the fair value of those guarantees:


		September 30, 2023		September 30, 2022		March 31, 2023
		December 31, 2023
		December 31, 2023
		December 31, 2023							December 31, 2022	March 31, 2023
Amounts guaranteed (not to exceed)	Amounts guaranteed (not to exceed)	$	93,554	$	103,434	$	152,032
Amounts outstanding under guarantee (1)	Amounts outstanding under guarantee (1)	18,819		26,460		83,420
Fair value of guarantees	Fair value of guarantees	1,458		1,206		5,262
Amounts due to local banks on behalf of suppliers for government subsidized rural credit financing	Amounts due to local banks on behalf of suppliers for government subsidized rural credit financing	68		102		12,529
(1) Most of the guarantees outstanding at September 30, 2023 expire within one year.
(1) Most of the guarantees outstanding at December 31, 2023 expire within one year.								(1) Most of the guarantees outstanding at December 31, 2023 expire within one year.

~~13.~~

14. Derivative Financial Instruments

The Company uses forward or option currency contracts to manage risks associated with foreign currency exchange rates on foreign operations. These contracts are for green tobacco purchases, processing costs, and selling, general, and administrative expenses. The Company recorded a net gain of ~~$1,386~~$1,548 and ~~$2,820~~$4,368 from its derivative financial instruments in cost of goods and services sold for the three and ~~six~~nine months ended ~~September 30,~~December 31, 2023, respectively. The Company recorded a net gain of ~~$1,848~~$1,966 and ~~$2,710~~$4,676 from its derivative financial instruments in cost of goods and services sold for the three and ~~six~~nine months ended ~~September 30,~~December 31, 2022, respectively.

As of ~~September 30,~~December 31, 2023 and 2022, and March 31, 2023, the Company recorded current derivative assets of ~~$132,~~ $0, $678, and $3,970 within other current assets, ~~respectively, and current derivative liabilities of $78, $531, and $0 within accrued expenses and other current liabilities,~~ respectively.

The following summarizes the U.S. Dollar notional amount of derivative contracts outstanding:

September 30, 2023 September 30, 2022 March 31, 2023
U.S. Dollar notional outstanding $ 14,327 $ 32,000 $ 63,622


	December 31, 2023		December 31, 2022		March 31, 2023


U.S. Dollar notional outstanding	$	—	$	32,000	$	63,622

~~14.~~15. Fair Value Measurements

The following summarizes the financial assets and liabilities measured at fair value on a recurring basis:


		September 30, 2023						September 30, 2022						March 31, 2023
		Level 2		Level 3		Total at Fair Value		Level 2		Level 3		Total at Fair Value		Level 2		Level 3		Total at Fair Value
		December 31, 2023
		December 31, 2023
		December 31, 2023																					December 31, 2022				March 31, 2023
	Level 2																				Level 2	Level 3		Total at Fair Value	Level 2	Level 3		Total at Fair Value	Level 2	Level 3	Total at Fair Value
Financial Assets:	Financial Assets:
Derivative financial instruments
Derivative financial instruments
Derivative financial instruments	Derivative financial instruments	$	132	$	—	$	132	$	—	$	—	$	—	$	3,970	$	—	$	3,970
Securitized beneficial interests	Securitized beneficial interests	—		24,393		24,393		—		22,842		22,842		—		19,522		19,522
Total assets	Total assets	$	132	$	24,393	$	24,525	$	—	$	22,842	$	22,842	$	3,970	$	19,522	$	23,492
Financial Liabilities:	Financial Liabilities:
Derivative financial instruments		$	78	$	—	$	78	$	531	$	—	$	531	$	—	$	—	$	—

Long-term debt(1)

Long-term debt(1)

Long-term debt(1)	Long-term debt(1)	481,248		507		481,755		417,542		577		418,119		523,758		514		524,272
Guarantees	Guarantees	—		1,458		1,458		—		1,206		1,206		—		5,262		5,262
Total liabilities	Total liabilities	$	481,326	$	1,965	$	483,291	$	418,073	$	1,783	$	419,856	$	523,758	$	5,776	$	529,534
(1) This fair value measurement disclosure does not affect the condensed consolidated balance sheets.	(1) This fair value measurement disclosure does not affect the condensed consolidated balance sheets.																			(1) This fair value measurement disclosure does not affect the condensed consolidated balance sheets.

The following summarizes the reconciliation of changes in Level 3 instruments measured on a recurring basis:


		Three Months Ended
		September 30, 2023						September 30, 2022
		Securitized Beneficial Interests		Long-Term Debt		Guarantees		Securitized Beneficial Interests		Long-Term Debt		Guarantees
	Three Months Ended																		Three Months Ended
	December 31,																		December 31,
	2023															2023			2022
	Securitized Beneficial Interests													Securitized Beneficial Interests	Long-Term Debt	Guarantees	Securitized Beneficial Interests	Long-Term Debt	Guarantees
Beginning balance	Beginning balance	$	19,641	$	509	$	5,764	$	22,762	$	660	$	2,601
Issuances of sales of receivables/guarantees	Issuances of sales of receivables/guarantees	—		—		1,200		—		—		481
Settlements	Settlements	(40,198)		(2)		(4,206)		(39,395)		—		(808)
Additions	Additions	47,637		—		—		41,816		—		—
Losses recognized in earnings	Losses recognized in earnings	(2,687)		—		(1,300)		(2,341)		(83)		(1,068)
Losses recognized in earnings
Losses recognized in earnings
Ending balance	Ending balance	$	24,393	$	507	$	1,458	$	22,842	$	577	$	1,206

Six Months Ended
September 30, 2023 September 30, 2022
Securitized Beneficial Interests Long-Term Debt Guarantees Securitized Beneficial Interests Long-Term Debt Guarantees
Beginning balance $ 19,522 $ 514 $ 5,262 $ 28,072 $ 246 $ 2,956
Issuances of sales of receivables/guarantees — — 2,254 — — 687
Settlements (73,381) (7) (4,761) (72,756) — (1,343)
Additions 84,277 — — 71,082 370 —
Losses recognized in earnings (6,025) — (1,297) (3,556) (39) (1,094)
Ending balance $ 24,393 $ 507 $ 1,458 $ 22,842 $ 577 $ 1,206


	Nine Months Ended
	December 31,
	2023						2022
	Securitized Beneficial Interests		Long-Term Debt		Guarantees		Securitized Beneficial Interests		Long-Term Debt		Guarantees
Beginning balance	$	19,522	$	514	$	5,262	$	28,072	$	246	$	2,956
Issuances of sales of receivables/guarantees	—		—		3,779		—		—		2,236
Settlements	(125,532)		(314)		(4,792)		(112,758)		—		(1,422)
Additions	129,031		—		—		131,392		325		—
Losses recognized in earnings	(8,709)		—		(2,546)		(9,056)		(39)		(2,018)
Ending balance	$	14,312	$	200	$	1,703	$	37,650	$	532	$	1,752

For the ~~six~~nine months ended ~~September 30,~~December 31, 2023 and 2022, the impact to earnings attributable to the change in unrealized losses on securitized beneficial interests was ~~$1,230~~$1,551 and ~~$597,~~$2,252, respectively.

~~15.~~16. Pension and Other Postretirement Benefits

The Company terminated one of its defined benefit pension plans in the U.K. ("U.K. Pension Plan") during the three-month period ended December 31, 2023. The U.K. Pension Plan was over-funded. During the three-month period ended December 31, 2023, the Company utilized the surplus assets to pay termination fees and received a $1,106 cash distribution from the plan termination. The Company recorded a noncash pension settlement charge of $12,008 during the three and nine months ended December 31, 2023, which included the disposition of the U.K. Pension Plan assets and the reclassification of $3,511 unrecognized net pension losses, net of $1,170 tax benefit, within accumulated other comprehensive income (loss) into the Company's condensed consolidated statements of operations.

Termination of the U.S. Pension Plan occurred during the three months ended December 31, 2022. The Company settled benefits with vested participants that elected a lump sum payout and made a cash contribution of $5,300 to fully fund the U.S. defined benefit pension plan ("U.S. Pension Plan") liabilities that was used to purchase a group annuity contract to administer payments to the remaining U.S. Pension Plan participants. The Company recorded pension settlement charges of $0 and $2,588 for the three and nine months ended December 31, 2022, respectively, which included the reclassification of $1,562 unrecognized net pension gains within accumulated other comprehensive income (loss) into the Company's condensed consolidated statements of operations.

17. Contingencies and Other Information

Brazilian Tax Credits

The government in the Brazilian State of Parana ("Parana") issued a tax assessment on October 26, 2007 with respect to local intrastate trade tax credits that result primarily from tobacco transferred between states within Brazil. At ~~September 30,~~December 31, 2023, the assessment for intrastate trade tax credits taken is ~~$2,636~~$2,727 and the total assessment including penalties and interest is

~~$10,525.~~ $11,013. On March 18, 2014, the government in Brazilian State of Santa Catarina also issued a tax assessment with respect to local intrastate trade tax credits that result primarily from tobacco transferred between states within Brazil. At ~~September 30,~~December 31, 2023, the assessment for intrastate trade tax credits taken is ~~$2,275~~$2,353 and the total assessment including penalties and interest is ~~$6,699.~~$6,997. The Company believes it has properly complied with Brazilian law and will contest any assessment through the judicial process. Should the Company lose in the judicial process, the loss of the intrastate trade tax credits would have a material impact on the financial statements of the Company.

The Company also has local intrastate trade tax credits in the Brazil State of Rio Grande do Sul. This jurisdiction permits the sale or transfer of excess credits to third parties, however approval must be obtained from the tax authorities. The Company has an agreement with the state government regarding the amounts and timing of credits that can be sold. The tax credits have a carrying value of ~~$19,329~~$17,068 as of ~~September 30,~~December 31, 2023. The intrastate trade tax credits are monitored for impairment in future periods based on market conditions and the Company’s ability to use or sell the tax credits.

Other Matters

In addition to the above-mentioned matters, the Company or certain of its subsidiaries are involved in other litigation or legal matters incidental to their business activities, including tax matters. While the outcome of these matters cannot be predicted with certainty, they are being vigorously defended and the Company does not currently expect that any of them will have a material adverse effect on its business or financial position. However, should one or more of these matters be resolved in a

manner adverse to its current expectation, the effect on the Company’s results of operations for a particular fiscal reporting period could be material.

~~16.~~18. Related Party Transactions

The Company engages in transactions with its equity method investees primarily for the procuring and processing of inventory. The following summarizes sale and purchase transactions with related parties:


		Three Months Ended				Six Months Ended
		September 30,
		2023		2022		2023		2022
	Three Months Ended										Three Months Ended		Nine Months Ended
	December 31,										December 31,		December 31,
	2023									2023	2022	2023	2022
Sales	Sales	$	10,399	$	9,928	$	21,217	$	20,550
Purchases	Purchases	63,110		50,555		101,899		76,396

The Company included the following related party balances in its condensed consolidated balance sheets:


	December 31, 2023														December 31, 2023			December 31, 2022			March 31, 2023	Location in Condensed Consolidated Balance Sheet
Accounts receivable, related parties									Accounts receivable, related parties	$	50		$	770		$	3,090		Other receivables

		September 30, 2023		September 30, 2022		March 31, 2023		Location in Condensed Consolidated Balance Sheet
Accounts receivable, related parties		$	12,927	$	2,657	$	3,090	Other receivables
Accounts payable, related parties

Accounts payable, related parties

Accounts payable, related parties	Accounts payable, related parties	46,987		13,537		20,438		Accounts payable	31,921		39,640	39,640		20,438	20,438		Accounts payable	Accounts payable
Advances from related parties	Advances from related parties	3,832		—		3,494		Advances from customers	Advances from related parties	4,062			3,494	3,494		3,494	3,494		Advances from customers	Advances from customers

Transactions with Significant Shareholders

As described in "Note ~~10.~~1 1 . Debt Arrangements," funds managed by the Glendon Investor, funds managed by the Monarch Investor, and funds managed by Owl Creek Asset Management, L.P., (such funds are collectively referred to as the "Investor-Affiliated Funds") held 2024 Notes and/or Exit Term Loans, were parties to the Initial DDTL Facility Credit Agreement and amendments thereto (including the DDTL Credit Agreement) and the Support Agreement, and received the New Secured Debt pursuant to the Debt Exchange Transactions.

Accrued expenses and other current liabilities as presented in the condensed consolidated balance sheets as of ~~September 30,~~December 31, 2023 and 2022, and March 31, 2023, includes ~~$9,480,~~$4,091, $~~4,085~~7,649, and $3,653, respectively, of interest payable to Investor-Affiliated Funds and CI Investments, Inc. ("CI Investments"), which is also a beneficial owner of greater than five percent of the Company's common stock. Interest expense as presented in the condensed consolidated statements of operations includes $~~10,294~~10,314 and ~~$20,369~~$30,683 for the three and ~~six~~nine months ended ~~September 30,~~December 31, 2023, respectively, and ~~$8,133~~$9,264 and ~~$16,230~~$25,494 for the three and ~~six~~nine months ended ~~September 30,~~December 31, 2022, respectively, that relates to the Investor-Affiliated Funds and CI Investments.

2021

~~17.~~19. Segment Information

The following summarizes segment information, with the All Other category being included for purposes of reconciliation of the respective balances below of the Leaf segment (the Company's sole reportable segment) to the condensed consolidated financial statements:


		Three Months Ended				Six Months Ended
		September 30,
		2023		2022		2023		2022
	Three Months Ended										Three Months Ended		Nine Months Ended
	December 31,										December 31,		December 31,
	2023									2023	2022	2023	2022
Sales and other operating revenues:	Sales and other operating revenues:
Leaf
Leaf
Leaf	Leaf	$	623,127	$	505,941	$	1,099,560	$	846,567
All Other	All Other	1,126		2,337		1,785		5,616
Consolidated sales and other operating revenues	Consolidated sales and other operating revenues	$	624,253	$	508,278	$	1,101,345	$	852,183

Segment operating income:
Segment operating income (loss):
Segment operating income (loss):
Segment operating income (loss):
Leaf
Leaf
Leaf	Leaf	$	50,309	$	35,800	$	88,238	$	47,429
All Other	All Other	(2,765)		(4,619)		(4,236)		(8,996)
Segment operating income	Segment operating income	47,544		31,181		84,002		38,433

Restructuring and asset impairment charges	Restructuring and asset impairment charges	1,254		4,045		1,294		4,345
Restructuring and asset impairment charges
Restructuring and asset impairment charges

Consolidated operating income	Consolidated operating income	$	46,290	$	27,136	$	82,708	$	34,088
Consolidated operating income
Consolidated operating income


		September 30, 2023		September 30, 2022		March 31, 2023
		December 31, 2023
		December 31, 2023
		December 31, 2023						December 31, 2022	March 31, 2023
Segment assets:	Segment assets:
Leaf
Leaf
Leaf	Leaf	$	1,697,063	$	1,651,217	$	1,544,798
All Other	All Other	45,391		46,848		37,665
Total assets	Total assets	$	1,742,454	$	1,698,065	$	1,582,463

~~18. Subsequent Event~~

~~Third Amendment to the ABL Credit Agreement~~

On October 24, 2023, the Company, the Borrowers, and Pyxus Parent entered into a Third Amendment to the ABL Credit Agreement (the "ABL Amendment"), with the lenders party thereto and PNC Bank, National Association, as Administrative Agent and Collateral Agent. The ABL Amendment amends the ABL Credit Agreement to, among other things:

•~~increase the aggregate amount of the revolving loan commitments under the ABL Credit Facility from $100,000 to $120,000;~~

•create a grid based commitment fee applicable to unused amounts under the ABL Credit Facility from a rate of 0.375% per annum to a rate of (i) 0.25% per annum when the outstanding borrowings equal or exceed $60,000, and (ii) 0.375% per annum when the outstanding borrowings are less than $60,000;

•~~reduces the requirement for determining permitted repayment of the New Term Loans, the 2024 Notes and the 2027 Notes; and~~

•~~loosens the events triggering application of the cash dominion provisions of the ABL Credit Agreement.~~

2122

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

Readers are cautioned that the statements contained in this report regarding expectations of our performance or other matters that may affect our business, results of operations, or financial condition are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements, which are based on current expectations of future events, may be identified by the use of words such as "strategy," "expects," "continues," "plans," "anticipates," "believes," "will," "estimates," "intends," "projects," "goals," "targets," and other words of similar meaning. These statements also may be identified by the fact that they do not relate strictly to historical or current facts. If underlying assumptions prove inaccurate, or if known or unknown risks or uncertainties materialize, actual results could vary materially from those anticipated, estimated, or projected. These risks and uncertainties include those discussed in this Quarterly Report on Form 10-Q, in our Annual Report on Form 10-K for the year ended March 31, 2023 and in our other filings with the Securities and Exchange Commission. These risks and uncertainties include: our reliance on a small number of significant customers; continued vertical integration by our customers; global shifts in sourcing customer requirements; shifts in the global supply and demand position for tobacco products; variation in our financial results due to growing conditions, customer indications and other factors; loss of confidence in us by our customers, farmers and other suppliers; migration of suppliers who have historically grown tobacco and from whom we have purchased tobacco toward growing other crops; risks related to our advancement of inputs to tobacco suppliers to be settled upon the suppliers delivering us unprocessed tobacco at the end of the growing season; risks that the tobacco we purchase directly from suppliers will not meet our customers’ quality and quantity requirements; weather and other environmental conditions that can affect the marketability of our inventory; international business risks, including unsettled political conditions, uncertainty in the enforcement of legal obligations, including the collection of accounts receivable, fraud risks, expropriation, import and export restrictions, exchange controls, inflationary economies, currency risks and risks related to the restrictions on repatriation of earnings or proceeds from liquidated assets of foreign subsidiaries; many of our operations are located in jurisdictions that pose a high risk of potential violations of the Foreign Corrupt Practices Act; risks and uncertainties related to geopolitical conflicts, including the armed conflict between Israel and ~~Hamas;~~Hamas and disruptions affecting Red Sea shipping; impacts of international sanctions on our ability to sell or source tobacco in certain regions; exposure to foreign tax regimes in which the rules are not clear, are not consistently applied and are subject to sudden change; fluctuations in foreign currency exchange and interest rates; competition with the other primary global independent leaf tobacco merchant and independent leaf merchants; disruption, failure or security breaches of our information technology systems and other cybersecurity risks; continued high inflation; we have identified material weaknesses related to our internal controls in certain prior years, and there can be no assurance that material weaknesses will not be identified in the future; regulations regarding environmental matters; risks related to our capital structure, including risks related to our significant debt and our ability to continue to finance our non-U.S. local operations with uncommitted short-term operating credit lines at the local level; our ability to continue to access capital markets to obtain long-term and short-term financing; potential failure of foreign banks in which our subsidiaries maintain deposits or the failure by such banks to transfer funds or honor withdrawals; the risk that, because our ability to generate cash depends on many factors beyond our control, we may be unable to generate the significant amount of cash required to service our indebtedness; our ability to refinance our current credit facilities at the same availability or at similar interest rates; failure to achieve our stated goals, which may adversely affect our liquidity; developments with respect to our liquidity needs and sources of liquidity; the volatility and disruption of global credit markets; failure by counterparties to derivative transactions to perform their obligations; increasing scrutiny and changing expectations from governments, as well as other stakeholders such as investors and customers, with respect to our environmental, social and governance policies, including sustainability policies; inherent risk of exposure to product liability claims, regulatory action and litigation facing our e-liquids business if its products are alleged to have caused significant loss, injury, or death; certain shareholders have the ability to exercise controlling influence on various corporate matters; reductions in demand for consumer tobacco products; risks and uncertainties related to pandemics or other widespread health crises and any related shipping constraints, labor shortages and supply-chain impacts; legislative and regulatory initiatives that may reduce consumption of consumer tobacco products and demand for our services and increase regulatory burdens on us or our customers; government actions that significantly affect the sourcing of tobacco, including governmental actions to identify and assess crop diversification initiatives and alternatives to leaf tobacco growing in countries whose economies depend upon tobacco production; governmental investigations into, and litigation concerning, leaf tobacco industry buying and other payment practices; and impact of potential regulations to prohibit the sale of cigarettes in the United States other than low-nicotine cigarettes.

We do not undertake to update any forward-looking statements that we may make from time to time.

Overview

The Company is a global agricultural company with over 150 years of experience delivering value-added products and services to businesses and customers. The Company is a trusted provider of responsibly sourced, independently verified, sustainable, and traceable products and ingredients.

2223

Executive Summary

~~The momentum from first quarter~~Through the nine months ended December 31, 2023, the Company continued ~~through the second quarter. We delivered solid~~to deliver revenue ~~improvement~~growth and ~~increased profitability by exercising~~improved profitability. Our operating discipline, ~~efficient management of~~improved working capital efficiency, and ~~leveraging our~~ geographic ~~diversification. Undersupply~~diversification contributed to an increase in total processed tobacco compared to the prior year. Our uncommitted levels of processed tobacco remain low, as undersupply conditions ~~continue to support our strategy to drive operational improvements by compressing our operating cycles.~~persist in the global tobacco market.

Results of Operations

										Three Months Ended September 30, 2023 and 2022
		Three Months Ended September 30,
								Change
Three Months Ended December 31, 2023 and 2022										Three Months Ended December 31, 2023 and 2022
	Three Months Ended December 31,														Three Months Ended December 31,
						Change										Change
(in millions, except per kilo amounts)	(in millions, except per kilo amounts)	2023			2022			$	%	(in millions, except per kilo amounts)	2023	2022	$	%
Sales and other operating revenues	Sales and other operating revenues	$	624.3		$	508.3		116.0	22.8
Cost of goods and services sold	Cost of goods and services sold	535.5			441.0			94.5	21.4
Gross profit*	Gross profit*	88.7			67.3			21.4	31.8
Selling, general, and administrative expenses	Selling, general, and administrative expenses	40.0			35.0			5.0	14.3
Other expense, net	Other expense, net	1.1			1.2			(0.1)	(8.3)
Restructuring and asset impairment charges	Restructuring and asset impairment charges	1.3			4.0			(2.7)	(67.5)
Operating income	Operating income	46.3			27.1			19.2	70.8

Loss on pension settlement	Loss on pension settlement	—			2.6			(2.6)	(100.0)
Loss on pension settlement
Loss on pension settlement
Interest expense, net	Interest expense, net	33.0			28.8			4.2	14.6
Income tax expense (benefit)		7.6			(1.2)			8.8	733.3
Income tax expense
Income from unconsolidated affiliates	Income from unconsolidated affiliates	2.1			1.6			0.5	31.3
Net (loss) income attributable to noncontrolling interests		(0.2)			—			(0.2)	(100.0)
Net income attributable to noncontrolling interests
Net income (loss) attributable to Pyxus International, Inc.*	Net income (loss) attributable to Pyxus International, Inc.*	$	8.1		$	(1.5)		9.6	640.0

Leaf:	Leaf:
Product revenue		$	585.8		$	475.6		110.2	23.2
Leaf:
Leaf:
Product revenues
Product revenues
Product revenues
Tobacco costs	Tobacco costs	484.7			388.7			96.0	24.7
Transportation, storage, and other period costs	Transportation, storage, and other period costs	22.2			23.9			(1.7)	(7.1)
Total cost of goods sold	Total cost of goods sold	506.9			412.5			94.4	22.9
Product revenue gross profit	Product revenue gross profit	78.9			63.1			15.8	25.0
Product revenue gross profit as a percent of sales	Product revenue gross profit as a percent of sales	13.5		%	13.3		%

Kilos sold	Kilos sold	111.7			101.4			10.3	10.2

Kilos sold

Kilos sold
Average price per kilo	Average price per kilo	$	5.24		$	4.69		0.55	11.7
Average cost per kilo	Average cost per kilo	4.54			4.07			0.47	11.5
Average gross profit per kilo	Average gross profit per kilo	0.70			0.62			0.08	12.9

Processing and other revenues
Processing and other revenues
Processing and other revenues	Processing and other revenues	$	37.3		$	30.3		7.0	23.1
Processing and other revenues costs of services sold	Processing and other revenues costs of services sold	27.2			23.0			4.2	18.3
Processing and other gross profit	Processing and other gross profit	10.1			7.3			2.8	38.4
Processing and other gross profit as a percent of sales	Processing and other gross profit as a percent of sales	27.1		%	24.2		%

All Other:	All Other:

All Other:

All Other:
Sales and other operating revenues
Sales and other operating revenues
Sales and other operating revenues	Sales and other operating revenues	$	1.2		$	2.3		(1.1)	(47.8)
Cost of goods and services sold	Cost of goods and services sold	1.4			5.4			(4.0)	(74.1)
Gross loss*		(0.3)			(3.1)			2.8	90.3
Gross loss as a percent of sales		(25.0)		%	(132.5)		%
Gross income (loss)
Gross income (loss) as a percent of sales
										* Amounts may not equal column totals due to rounding.
* Amounts may not equal column totals due to rounding.

* Amounts may not equal column totals due to rounding.

2324

Sales and other operating revenues were $655.6 million for the three months ended December 31, 2022 and $529.8 million for the three months ended December 31, 2023, a decrease of $125.8 million, or 19.2%. This decrease was primarily due to a 22.7% decrease in leaf volume, partially offset by a 3.7% increase in average price per kilo. The decrease in leaf volume was primarily due to accelerated North America shipments from the current quarter into the first half of the fiscal year and delayed shipments from South America. The increase in average price per kilo was mainly due to higher tobacco prices.

Cost of goods and services sold were $567.8 million for the three months ended December 31, 2022 and $437.3 million for the three months ended December 31, 2023, a decrease of $130.5 million, or 23.0%. This decrease was mainly due to the decrease in sales and other operating revenues.

Gross profit as a percent of sales increased from 13.4% for the three months ended December 31, 2022 to 17.5% for the three months ended December 31, 2023. Average gross profit per kilo for product revenue was $0.64 for the three months ended December 31, 2022 and $0.83 for the three months ended December 31, 2023, an increase of $0.19 per kilo, or 29.7%. These increases were primarily due to a more favorable customer mix.

Selling, general, and administrative expenses were $37.1 million for the three months ended December 31, 2022 and $42.4 million for the three months ended December 31, 2023, an increase of $5.3 million, or 14.3%. This increase was primarily due to increased accrued bonus compensation.

Other expense, net was $9.0 million for the three months ended December 31, 2022 and $2.3 million for the three months ended December 31, 2023, a decrease of $6.7 million, or 74.4%. This decrease was mainly due to lower utilization of the Company's securitization programs.

Loss on pension settlement of $12.0 million for the three months ended December 31, 2023 was due to the termination of an over-funded defined benefit pension plan in the U.K. See "Note 16. Pension and Other Postretirement Benefits" to the "Notes to Condensed Consolidated Financial Statements" for additional information.

Income tax expense was $17.9 million for the three months ended December 31, 2022 and $6.2 million for the three months ended December 31, 2023, a decrease of $11.7 million, or 65.4%. This decrease was primarily due to deferred tax valuations allowances, the favorable net foreign exchange effect, and variations in the jurisdictional mix of earnings.


Nine Months Ended December 31, 2023 and 2022
	Nine Months Ended December 31,
							Change
(in millions, except per kilo amounts)	2023			2022			$	%
Sales and other operating revenues	$	1,631.2		$	1,507.7		123.5	8.2
Cost of goods and services sold	1,376.8			1,311.9			64.9	4.9
Gross profit	254.4			195.9			58.5	29.9
Selling, general, and administrative expenses	116.5			106.7			9.8	9.2
Other expense, net	6.0			9.1			(3.1)	(34.1)
Restructuring and asset impairment charges	1.4			4.4			(3.0)	(68.2)
Operating income	130.5			75.7			54.8	72.4
Loss on deconsolidation/disposition of subsidiaries	—			0.6			(0.6)	(100.0)
Loss on pension settlement	12.0			2.6			9.4	361.5
Interest expense, net	95.8			85.6			10.2	11.9
Income tax expense	16.4			15.8			0.6	3.8
Income from unconsolidated affiliates	6.5			10.7			(4.2)	(39.3)
Net income attributable to noncontrolling interests	0.1			0.2			(0.1)	(50.0)
Net income (loss) attributable to Pyxus International, Inc.	$	12.7		$	(18.5)		31.2	168.6

Leaf:
Product revenue	$	1,537.3		$	1,423.6		113.7	8.0
Tobacco costs	1,242.4			1,164.8			77.6	6.7
Transportation, storage, and other period costs	66.0			77.8			(11.8)	(15.2)
Total cost of goods sold	1,308.4			1,242.7			65.7	5.3
Product revenue gross profit	228.9			181.0			47.9	26.5
Product revenue gross profit as a percent of sales	14.9		%	12.7		%

Kilos sold	297.2			302.9			(5.7)	(1.9)
Average price per kilo	$	5.17		$	4.70		0.47	10.0
Average cost per kilo	4.40			4.10			0.30	7.3
Average gross profit per kilo	0.77			0.60			0.17	28.3

Processing and other revenues	$	91.4		$	75.2		16.2	21.5
Processing and other revenues costs of services sold	66.5			56.1			10.4	18.5
Processing and other gross profit	24.9			19.1			5.8	30.4
Processing and other gross profit as a percent of sales	27.2		%	25.4		%

All Other:
Sales and other operating revenues	$	2.5		$	8.9		(6.4)	(71.9)
Cost of goods and services sold	1.9			13.1			(11.2)	(85.5)
Gross profit (loss)	0.6			(4.2)			4.8	114.3
Gross profit (loss) as a percent of sales	24.0		%	(47.3)		%

* Amounts may not equal column totals due to rounding.

Sales and other operating revenues were ~~$508.3~~$1,507.7 million for the ~~three~~nine months ended ~~September 30,~~December 31, 2022 and ~~$624.3~~$1,631.2 million for the ~~three~~nine months ended ~~September 30,~~December 31, 2023, an increase of ~~$116.0~~$123.5 million, or ~~22.8%~~8.2%. This increase was ~~primarily~~ due to ~~a 10.2% increase~~larger crop volumes in ~~leaf volume~~Africa and ~~a 11.7% increase in average price per kilo. The increase in leaf volume was primarily due to~~ the ~~accelerated~~ timing of shipments ~~from North America and~~in South ~~America and growth from Africa and Asia.~~ ~~The increase in average~~America. Average price per kilo ~~was~~increased by 10.0% mainly duedue to higher tobacco prices.

Cost of goods and services sold were ~~$441.0~~$1,311.9 million for the ~~three~~nine months ended ~~September 30,~~December 31, 2022 and ~~$535.5~~$1,376.8 million for the ~~three~~nine months ended ~~September 30,~~December 31, 2023, an increase of ~~$94.5~~$64.9 million, or ~~21.4%~~4.9%. This increase was mainly due to the increase in sales and other operating revenues. A~~verage~~Average cost per kilo increased primarily ~~due~~ due to undersupply conditions and inflation.

Gross profit as a percent of sales increased from ~~13.2%~~13.0% for the ~~three~~nine months ended ~~September 30,~~December 31, 2022 to ~~14.2%~~15.6% for the ~~three~~nine months ended ~~September 30,~~December 31, 2023. Average gross profit per kilo for product revenue was ~~$0.62~~$0.60 for the ~~three~~nine months ended ~~September 30,~~December 31, 2022 and ~~$0.70~~$0.77 for the ~~three~~nine months ended ~~September 30,~~December 31, 2023, an increase of ~~$0.08~~$0.17 per kilo, or ~~12.9%~~28.3%. These increases were ~~primaril~~primarily y due to ~~product mix in South America~~a more favorable customer and ~~customer mix in Africa and Europe.~~regional mix.

Selling, general, and administrative expenses were $~~35.0~~106.7 million for for the ~~three~~nine months ended ~~September 30,~~December 31, 2022 and $~~40.0~~116.5 million for the ~~three~~nine months ended ~~September 30,~~December 31, 2023, an increase of $~~5.0~~9.8 million, or ~~14.3%~~9.2%. This increase ~~was primarily due to increased accrued bonus compensation and professional fees.~~

~~Income tax (benefit) expense was $(1.2) million for the~~ ~~three months ended September 30, 2022~~ ~~and $7.6 million for the~~ ~~three months ended September 30, 2023, an increase of $8.8 million, or 733.3%.~~ ~~This increase was driven by an~~ increase in the Company's liability for unrecognized tax benefits in Africa, the impact of changes in valuation allowance for non-deductible interest, U.S. taxation of foreign earnings, and variations in the jurisdictional mix of earnings.

Six Months Ended September 30, 2023 and 2022
Six Months Ended September 30,
Change
(in millions, except per kilo amounts) 2023 2022 $ %
Sales and other operating revenues $ 1,101.4 $ 852.2 249.2 29.2
Cost of goods and services sold 939.5 744.1 195.4 26.3
Gross profit* 161.8 108.1 53.7 49.7
Selling, general, and administrative expenses 74.1 69.6 4.5 6.5
Other expense, net 3.7 0.1 3.6 3,600.0
Restructuring and asset impairment charges 1.3 4.3 (3.0) (69.8)
Operating income 82.7 34.1 48.6 142.5
Loss on deconsolidation/disposition of subsidiaries — 0.6 (0.6) (100.0)
Loss on pension settlement — 2.6 (2.6) (100.0)
Interest expense, net 63.8 54.3 9.5 17.5
Income tax expense (benefit) 10.2 (2.1) 12.3 585.7
(Loss) income from unconsolidated affiliates (0.1) 5.3 (5.4) (101.9)
Net (loss) income attributable to noncontrolling interests (0.2) 0.1 (0.3) (300.0)
Net income (loss) attributable to Pyxus International, Inc.* $ 8.9 $ (16.2) 25.1 154.9
Leaf:
Product revenue $ 1,036.8 $ 798.5 238.3 29.8
Tobacco costs 847.7 654.6 193.1 29.5
Transportation, storage, and other period costs 42.8 44.5 (1.7) (3.8)
Total cost of goods sold 890.5 699.1 191.4 27.4
Product revenue gross profit* 146.2 99.3 46.9 47.2
Product revenue gross profit as a percent of sales 14.1 % 12.4 %
Kilos sold 197.2 173.5 23.7 13.7
Average price per kilo $ 5.26 $ 4.60 0.66 14.3
Average cost per kilo 4.52 4.03 0.49 12.2
Average gross profit per kilo 0.74 0.57 0.17 29.8
Processing and other revenues $ 62.8 $ 48.1 14.7 30.6
Processing and other revenues costs of services sold 47.2 35.5 11.7 33.0
Processing and other gross profit 15.6 12.5 3.1 24.8
Processing and other gross profit as a percent of sales 24.8 % 26.1 %
All Other:
Sales and other operating revenues $ 1.8 $ 5.6 (3.8) (67.9)
Cost of goods and services sold 1.8 9.4 (7.6) (80.9)
Gross loss — (3.8) 3.8 100.0
Gross loss as a percent of sales — % (67.8) %
* Amounts may not equal column totals due to rounding.

~~Sales and other operating revenues were $852.2 million for the six months ended September 30, 2022 and $1,101.4 million for th~~e six months ended September 30, 2023, an increase of $249.2 million, or 29.2%. This increase was primarily due to a 13.7% increase in leaf volume and a 14.3% increase in average price per kilo. The increase in leaf volume was primarily due to the accelerated timing of shipments from Africa, North America, and South America and growth from Africa and Asia. The increase in average price per kilo was mainly due to higher tobacco prices.

Cost of goods and services sold were $744.1 million for the six months ended September 30, 2022 and $939.5 million for the six months ended September 30, 2023, an increase of $195.4 million, or 26.3%. This increase was mainly due to the increase in ~~sales and other operating revenues. Average cost per kilo increased primarily due to undersupply conditions and inflation.~~

Gross profit as a percent of sales increased from 12.7% for the six months ended September 30, 2022 to 14.7% for the six months ended September 30, 2023. Average gross profit per kilo for product revenue was $0.57 for the six months ended September 30, 2022 and $0.74 for the six months ended September 30, 2023, an increase of $0.17 per kilo, or 29.8%. These increases were ~~primarily due to product mix in Asia and customer mix in Africa and Europe.~~

~~Selling, general, and administrative expenses~~ ~~were~~ ~~$69.6 million for the~~ ~~six months ended September 30, 2022~~ ~~and~~ ~~$74.1 million~~ ~~for the~~ ~~six months ended September 30, 2023, an increase of~~ ~~$4.5 million, or 6.5%. This increase~~ was primarily due to increased accrued bonus compensation and professional fees.

Interest expense, net was ~~$54.3~~$85.6 million forfor the ~~six~~nine months ended ~~September 30,~~December 31, 2022 and ~~$63.8~~$95.8 million for the ~~six~~nine months ended ~~September 30,~~December 31, 2023,, an increase of ~~$9.5~~$10.2 million, or ~~17.5%~~11.9%. This increase was due to higher average outstanding balances on seasonal credit lines from financing the purchase of greater volumes of more expensive green tobacco compared to the prior year, primarily in Africa and South America, and increased variable interest ~~rates on foreign seasonal lines of credit.~~rates.

~~Income tax (benefit) expense was~~ ~~$(2.1)~~Loss on pension settlement of $2.6 million for the ~~six~~nine months ended ~~September 30,~~December 31, 2022 ~~and~~ ~~$10.2~~ was attributable to the termination of a U.S. defined benefit pension plan in the period, while the loss on pension settlement of $12.0 million for the ~~six~~nine months ended ~~September 30,~~December 31, 2023, was due to the termination of an ~~increase~~ ~~of $12.3 million, or~~ ~~585.7%. This increase was driven by an increase~~over-funded defined benefit pension plan in the ~~Company's liability~~U.K. See "Note 16. Pension and Other Postretirement Benefits" to the "Notes to Condensed Consolidated Financial Statements" for ~~unrecognized tax benefits in Africa, the U.S. taxation of foreign earnings, and variations in the jurisdictional mix of earnings.~~additional information.

Liquidity and Capital Resources

Overview

Our primary sources of liquidity are cash generated from operations, short-term borrowings under our foreign seasonal lines of credit, availability under our ABL Credit Facility, and cash collections from our securitized receivables. Our liquidity requirements are affected by various factors from our core tobacco leaf business, including crop seasonality, foreign currency and interest rates, green tobacco prices, customer mix, crop size, and quality. Our leaf tobacco business is seasonal, and purchasing, processing, and selling activities have several associated peaks where cash on-hand and outstanding indebtedness may vary significantly compared to year end. The first three quarters of our fiscal year generally represent the peak of our working capital requirements.

We believe our sources of liquidity will be sufficient to fund our anticipated operating needs for the next twelve months. During such time our liquidity needs for operations may approach the levels of our anticipated available cash and permitted borrowings under our credit facilities. Unanticipated developments affecting our liquidity needs, including with respect to the foregoing factors, and sources of liquidity, including impacts affecting our cash flows from operations and the availability of capital resources (including an inability to renew or refinance seasonal lines of credit), may result in a deficiency in liquidity. To address a potential liquidity deficiency, we may undertake plans to minimize cash outflows, which could include exiting operations that do not generate positive cash flow.

Debt Financing

We continue to finance our business with a combination of short-term and long-term credit lines, the long-term debt securities, advances from customers, and cash from operations when available. See "Note 1 101 . Debt Arrangements~~" and "Note 18. Subsequent Events~~" to the "Notes to Condensed Consolidated Financial Statements" for a summary of our short-term and long-term debt.

We continuously monitor and, as available, adjust funding sources as needed to enhance and drive various business opportunities. From time to time we may take steps to reduce our debt or otherwise improve our financial position. Such actions could include prepayments, open market debt repurchases, negotiated repurchases, other redemptions or retirements of outstanding debt, and refinancing of debt. The amount of prepayments or the amount of debt that may be repurchased, refinanced, or otherwise retired, if any, will depend on market conditions, trading levels of our debt, our cash position, compliance with debt covenants, and other considerations.

2627

The following summarizes our total borrowing capacity at ~~September 30,~~December 31, 2023 and 2022 under our short-term and long-term credit lines and letter of credit facilities and the remaining available amount after the reduction for outstanding borrowings and amounts reserved for outstanding letters of credit:

September 30, 2023
(in millions) Total Borrowing Capacity Remaining Amount Available
ABL Credit Facility $ 100.0 $ 100.0
Foreign seasonal lines of credit 652.8 130.2
Other long-term debt 0.6 0.2
Letters of credit 10.5 3.7
Total $ 763.9 $ 234.1


	December 31, 2023
(in millions)	Total Borrowing Capacity		Remaining Amount Available
ABL Credit Facility	$	120.0	$	120.0
Foreign seasonal lines of credit	692.2		250.2
Other long-term debt	0.4		0.2
Letters of credit	8.1		3.4
Total	$	820.7	$	373.8


		September 30, 2022
	December 31, 2022								December 31, 2022
(in millions)	(in millions)	Total Borrowing Capacity		Remaining Amount Available		(in millions)	Total Borrowing Capacity	Remaining Amount Available
ABL Credit Facility	ABL Credit Facility	$	100.0	$	45.0
Foreign seasonal lines of credit	Foreign seasonal lines of credit	714.4		165.9
Other long-term debt	Other long-term debt	0.6		0.1
Letters of credit	Letters of credit	18.4		4.1
Total	Total	$	833.4	$	215.1

The remaining amount available under the ABL Credit Facility increased $20.0 million when compared to the prior period as a result of the Company entering into the Third Amendment to the ABL Credit Agreement on October 24, 2023, which among other things, increased the aggregate amount of revolving loan commitments from $100.0 million to $120.0 million. See "Note 11. Debt Arrangements" to the "Notes to Condensed Consolidated Financial Statements" for additional information.

Net Debt

We refer to "Net debt," a non-GAAP measure, as total debt liabilities less cash and cash equivalents. We believe this non-GAAP financial measure is useful to monitor leverage and to evaluate changes to the Company's capital structure. A limitation associated with using net debt is that it subtracts cash and cash equivalents, and therefore, may imply that management intends to use cash and cash equivalents to reduce outstanding debt and that cash held in certain jurisdictions can be applied to repay obligations owing in other jurisdictions and without reduction for applicable taxes. In addition, net debt suggests that our debt obligations are less than the most comparable GAAP measure indicates. The following summarizes the computation of net debt:


(in millions)	(in millions)	September 30, 2023		September 30, 2022		March 31, 2023		(in millions)	December 31, 2023		December 31, 2022	March 31, 2023
Notes payable	Notes payable	$	570.0	$	548.5	$	382.5
Current portion of long-term debt	Current portion of long-term debt	20.2		0.1		0.1
Long-term debt (1)	Long-term debt (1)	574.0		646.1		618.4
Total debt liabilities*	Total debt liabilities*	$	1,164.2	$	1,194.8	$	1,001.0
Less: Cash and cash equivalents	Less: Cash and cash equivalents	112.1		114.1		136.7
Net debt*	Net debt*	$	1,052.1	$	1,080.7	$	864.3
* Amounts may not equal column totals due to rounding	* Amounts may not equal column totals due to rounding
										(1) The fluctuation in long-term debt from September 30, 2022 and March 31, 2023 is due principally to the reclassification of the 10.0% Notes due August 24, 2024 from long-term debt to current portion of long-term debt in the current quarter. In addition, there have been net repayments on the outstanding indebtedness under the ABL Credit Facility for each of these periods. Weighted average borrowings outstanding under the ABL Credit Facility were $27.3 million and $53.5 million for the three and six months ended September 30, 2023, respectively.
(1) Includes amounts outstanding under the ABL Credit Facility. Weighted average borrowings outstanding under the ABL Credit Facility were $51.0 million and $52.6 million for the three and nine months ended December 31, 2023, respectively.

(1) Includes amounts outstanding under the ABL Credit Facility. Weighted average borrowings outstanding under the ABL Credit Facility were $51.0 million and $52.6 million for the three and nine months ended December 31, 2023, respectively.

(1) Includes amounts outstanding under the ABL Credit Facility. Weighted average borrowings outstanding under the ABL Credit Facility were $51.0 million and $52.6 million for the three and nine months ended December 31, 2023, respectively.

For the ~~six~~nine months ended ~~September 30,~~December 31, 2023, the Company accelerated the purchase of higher volumes of ~~tobacco~~inventory against the rising costs of green tobacco through more efficient use of foreign seasonal credit ~~lines. In addition,~~lines and the ~~Company expanded~~ABL Credit Facility. Increased sales and other operating revenues for the ~~number of securitization programs and increased~~nine months ended December 31, 2023 contributed to faster repayments on outstanding foreign seasonal lines when compared to the ~~utilization of existing securitization facilities to collect cash from tobacco sales more quickly. This resulted~~prior nine-month period, resulting in higher available amounts for use under foreign seasonal credit lines, and the ability to ~~generate excess cash to~~ fully ~~repay~~reduce indebtedness under the ABL Credit Facility as of ~~September 30,~~December 31, 2023.

2728

Working Capital

The following summarizes our working capital:


(in millions except for current ratio)	(in millions except for current ratio)	September 30, 2023		September 30, 2022		March 31, 2023		(in millions except for current ratio)	December 31, 2023		December 31, 2022		March 31, 2023
Cash, cash equivalents, and restricted cash	Cash, cash equivalents, and restricted cash	$	117.7	$	115.8	$	138.9
Trade and other receivables, net	Trade and other receivables, net	261.3		220.6		202.7
Inventories and advances to tobacco suppliers	Inventories and advances to tobacco suppliers	944.8		938.8		817.4
Recoverable income taxes	Recoverable income taxes	5.1		12.0		5.8
Prepaid expenses and other current assets	Prepaid expenses and other current assets	52.0		50.9		55.7
Total current assets*	Total current assets*	$	1,380.9	$	1,338.1	$	1,220.6

Notes payable	Notes payable	$	570.0	$	548.5	$	382.5
Notes payable
Notes payable
Accounts payable	Accounts payable	153.2		103.5		170.3
Advances from customers	Advances from customers	46.1		43.8		42.5
Accrued expenses and other current liabilities	Accrued expenses and other current liabilities	94.0		76.0		92.7
Income taxes payable	Income taxes payable	12.6		5.3		18.3
Operating leases payable	Operating leases payable	8.4		8.6		8.7
Current portion of long-term debt	Current portion of long-term debt	20.2		0.1		0.1
Total current liabilities*		$	904.4	$	785.8	$	715.1
Total current liabilities

Current ratio
Current ratio
Current ratio	Current ratio	1.5 to 1		1.7 to 1				1.6 to 1		1.5 to 1		1.7 to 1
Working capital	Working capital	$	476.5	$	552.3	$	505.5
* Amounts may not equal column totals due to rounding	* Amounts may not equal column totals due to rounding

Working capital ~~declined~~improved from ~~September 30,~~December 31, 2022 to ~~September 30,~~December 31, 2023 by ~~$75.8~~$89.0 million, or ~~13.7%~~22.0%, primarily due to ~~higher outstanding amounts on foreign seasonal lines~~the reduction in the current portion of ~~credit~~long-term debt from the February 6, 2023 debt exchange that extended maturities for most of the Company's term loans and senior secured notes. The Company also utilized cash in ~~Africa and increased accounts payable balances in Asia and South America from financing~~the current year for the purchase ~~of greater volumes~~ of more expensive green tobacco ~~compared to the prior year, as well as the reclassification of the remaining 10.0% Notes~~and faster repayments on outstanding after the February 6, 2023 exchange due August 24, 2024 from long-term debt to current portion of long-term debt during the current-year quarter. The Company also utilized cash to fully repay indebtedness under the ABL Credit Facility, which is recorded within long-term debt in the condensed consolidated balance sheets.foreign seasonal lines.

Inventories

The following summarizes inventory committed to a customer and uncommitted inventory balances for processed tobacco:


(in millions)	(in millions)	September 30, 2023		September 30, 2022		March 31, 2023		(in millions)	December 31, 2023	December 31, 2022	March 31, 2023
Committed	Committed	$	622.1	$	677.9	$	479.4
Uncommitted	Uncommitted	24.7		34.2		19.0
Total processed tobacco	Total processed tobacco	$	646.8	$	712.1	$	498.4

Total processed tobacco ~~decreased~~increased from ~~September 30,~~December 31, 2022 to ~~September 30,~~December 31, 2023 by ~~$65.3~~$87.1 million, or ~~9.2%~~15.2%, primarily due to ~~higher sales of inventories.~~larger crop sizes in Africa. Uncommitted levels of processed tobacco continue to remain low, as undersupply conditions persist in the global tobacco market. See "Note 67 . Inventories, Net" to the "Notes to Condensed Consolidated Financial Statements" for additional information.

Sources and Uses of Cash

We typically finance our non-U.S. tobacco operations with short-term foreign seasonal lines of credit, normally extending for a term of 180 to 365 days, corresponding to the tobacco crop cycle in that market. These short-term foreign seasonal lines of credit are typically uncommitted and provide lenders the right to cease making loans and demand repayment of loans. These short-term foreign seasonal lines of credit are generally renewed at the outset of each tobacco season. We maintain various

2829

other financing arrangements to meet the cash requirements of our businesses. See "Note 1 101 . Debt Arrangements" to the "Notes to Condensed Consolidated Financial Statements" for additional information.

We utilize capital in excess of cash flow from operations to finance accounts receivable, inventory, and advances to tobacco suppliers in foreign countries. In addition, we may periodically elect to purchase, redeem, repay, retire, or cancel indebtedness prior to stated maturity under our various foreign credit lines.

As of ~~September 30,~~December 31, 2023, our cash, cash equivalents, and restricted cash was ~~$117.7~~$94.7 million of which approximately ~~$72.8~~$61.8 million was held in foreign jurisdictions, certain of which are subject to exchange controls and tax consequences that could limit our ability to fully repatriate these funds. Fluctuation of the U.S. dollar versus many of the currencies in which we have costs may have an impact on our working capital requirements. We will continue to monitor and hedge foreign currency costs, as needed.

The following summarizes the sources and uses of our cash flows:

Six Months Ended
September 30,
(in millions) 2023 2022
Net income (loss) $ 8.7 $ (16.1)
Trade and other receivables (143.2) (48.4)
Inventories and advances to tobacco suppliers (128.6) (146.5)
Payables and accrued expenses (10.3) (76.6)
Advances from customers 3.6 (9.2)
Other 14.4 10.1
Net cash used in operating activities $ (255.4) $ (286.7)
Collections from beneficial interests in securitized trade receivables 79.3 76.2
Other (6.2) (0.8)
Net cash provided by investing activities $ 73.1 $ 75.4
Net proceeds from short-term borrowings 192.2 176.3
Net repayment of revolving loan facilities (25.0) (35.0)
Other (3.9) (19.5)
Net cash provided by financing activities $ 163.3 $ 121.8
Effect of exchange rate changes on cash (2.2) 3.9
Decrease in cash, cash equivalents, and restricted cash* $ (21.2) $ (85.5)
* Amounts may not equal column totals due to rounding


	Nine Months Ended
	December 31,
(in millions)	2023		2022
Net income (loss)	$	12.8	$	(18.3)
Trade and other receivables	(170.1)		(91.2)
Inventories and advances to tobacco suppliers	(50.3)		18.5

Other	(9.2)		(19.6)
Net cash used in operating activities	$	(216.8)	$	(110.6)
Collections from beneficial interests in securitized trade receivables	127.3		122.6
Other	(10.4)		(5.2)
Net cash provided by investing activities	$	116.9	$	117.4
Net proceeds from short-term borrowings	93.4		116.5

Net repayment of revolving loan facilities	(25.0)		(90.0)


Other	(5.8)		(20.0)
Net cash provided by financing activities	$	62.6	$	6.5
Effect of exchange rate changes on cash	(6.8)		3.8
(Decrease) increase in cash, cash equivalents, and restricted cash*	$	(44.2)	$	17.1



* Amounts may not equal column totals due to rounding

The ~~decrease~~change in cash, cash equivalents, and restricted cash for the ~~six~~nine months ended ~~September 30,~~December 31, 2023 compared to the ~~six~~nine months ended ~~September 30,~~December 31, 2022 ~~improved~~decreased by ~~$64.3~~$61.3 million. This ~~improvement~~decrease was driven by increased receivables from greater sales ~~volumes, which contributed to higher inventory turnover, as well as increased foreign seasonal lines~~ of ~~credit~~processed tobacco near the end of the quarter, resulting in ~~Africa and South America and increased accounts payable balances in Asia and South America from financing the purchase~~lower utilization of securitization programs, purchases of greater ~~volumes~~volume of more expensive green tobacco, ~~compared to~~and faster repayments on outstanding foreign seasonal lines. These decreases were partially offset by improved profitability and lower net repayments on the ~~prior year. In addition, costs incurred to refinance and partially pay down the DDTL Facility did not reoccur in the current period.~~ABL Credit Facility.

Planned Capital Expenditures

Capital investments in our leaf operations were primarily for routine replacement of machinery and equipment, as well as investments in assets that will add value for our customers and increase our efficiency. We incurred approximately ~~$9.2~~$14.4 million in capital expenditures for the ~~six~~nine months ended ~~September 30,~~December 31, 2023, and are expecting to incur an additional ~~$11.9~~$6.7 million for the remainder of the fiscal year ending March 31, 2024.

2930

Pension and Postretirement Health and Life Insurance Benefits

The following summarizes cash contributions to pension and postretirement health and life insurance benefits:


	Nine Months Ended
	~~Six Months Ended~~December 31,
(in millions)	~~September 30,~~ 2023
Contributions made during the period	$	~~2.2~~3.3
Contributions expected for the remainder of the fiscal year	~~2.5~~1.4
Total	$	4.7

No cash dividends on shares of common stock of Pyxus International, Inc. were paid to shareholders during the ~~six~~nine months ended ~~September 30,~~December 31, 2023. As of ~~September 30,~~December 31, 2023, the payment of such dividends is restricted under the terms of our debt agreements.

Critical Accounting Policies and Estimates

As of the date of this report, there are no material changes to the critical accounting policies and estimates previously disclosed in Part II, Item 7 "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2023.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

There have been no significant changes to our market risk exposures since March 31, 2023. For a discussion of our exposure to market risk, see Part II, Item 7A "Quantitative and Qualitative Disclosures About Market Risk" contained in our Annual Report on Form 10-K for the fiscal year ended March 31, 2023.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended (the "Exchange Act")) designed to provide reasonable assurance that the information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and that this information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure. Due to inherent limitations, our disclosure controls and procedures, however well designed and operated, can provide only reasonable assurance (not absolute) that the objectives of the disclosure controls and procedures are met.

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as required by Rule 13a-15(b) of the Exchange Act), as of ~~September 30,~~December 31, 2023. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Exchange Act) were effective to provide reasonable assurance as of ~~September 30,~~December 31, 2023.

Changes in Internal Control over Financial Reporting

As required by Rule 13a-15(d) under the Exchange Act, our management, including our Chief Executive Officer and Chief Financial Officer, have evaluated our internal control over financial reporting to determine whether any changes occurred during the quarter covered by this quarterly report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

There were no changes that occurred during the three months ended ~~September 30,~~December 31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Part II. Other Information

Item 1. Legal Proceedings

See "Note 1 57 . Contingencies and Other Information" to the "Notes to Condensed Consolidated Financial Statements" for additional information with respect to legal proceedings, which are incorporated by reference herein.

3032

Item 1A. Risk Factors

In addition to the other information set forth in this report and in our other filings with the Securities and Exchange Commission, investors should carefully consider our risk factors, which could materially affect our business, financial condition, or operating results. As of the date of this report, there are no material changes or updates to the risk factors previously disclosed in Part I, Item 1A "Risk Factors" in the ~~Company's~~Company's Annual Report on Form 10-K for the fiscal year ended March 31, ~~2023~~.2023.

Item 5. Other Information

During the three months ended December 31, 2023, none of the Company's directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted or terminated a "Rule 10b5-1 trading arrangement" or a "non-Rule 10b5-1 trading arrangement" (as such terms are defined in Item 408 of Regulation S-K).

Item 6. Exhibits

10.01

Third Amendment to ABL Credit Agreement dated as of October 24, 2023 by and among Pyxus Holdings, Inc., the other borrowers and guarantors party thereto, the lenders party thereto and PNC Bank, National Association, as administrative agent and collateral agent

31.01

Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)

31.02

Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)

Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith)

101.INS

XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document (filed herewith)

101.SCH

Inline XBRL Taxonomy Extension Schema (filed herewith)

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase (filed herewith)

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase (filed herewith)

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase (filed herewith)

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase (filed herewith)

104

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

3133



SIGNATURE




Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


						Pyxus International, Inc.



Date: ~~November~~February 14, ~~2023~~2024						/s/ Philip C. Garofolo
						Philip C. Garofolo
						Vice President Finance and Chief Accounting Officer
						(Principal Accounting Officer)

3234


Six Months Ended September 30, 2023 and 2022
	Six Months Ended September 30,
							Change
(in millions, except per kilo amounts)	2023			2022			$	%
Sales and other operating revenues	$	1,101.4		$	852.2		249.2	29.2
Cost of goods and services sold	939.5			744.1			195.4	26.3
Gross profit*	161.8			108.1			53.7	49.7
Selling, general, and administrative expenses	74.1			69.6			4.5	6.5
Other expense, net	3.7			0.1			3.6	3,600.0
Restructuring and asset impairment charges	1.3			4.3			(3.0)	(69.8)
Operating income	82.7			34.1			48.6	142.5
Loss on deconsolidation/disposition of subsidiaries	—			0.6			(0.6)	(100.0)
Loss on pension settlement	—			2.6			(2.6)	(100.0)
Interest expense, net	63.8			54.3			9.5	17.5
Income tax expense (benefit)	10.2			(2.1)			12.3	585.7
(Loss) income from unconsolidated affiliates	(0.1)			5.3			(5.4)	(101.9)
Net (loss) income attributable to noncontrolling interests	(0.2)			0.1			(0.3)	(300.0)
Net income (loss) attributable to Pyxus International, Inc.*	$	8.9		$	(16.2)		25.1	154.9

Leaf:
Product revenue	$	1,036.8		$	798.5		238.3	29.8
Tobacco costs	847.7			654.6			193.1	29.5
Transportation, storage, and other period costs	42.8			44.5			(1.7)	(3.8)
Total cost of goods sold	890.5			699.1			191.4	27.4
Product revenue gross profit*	146.2			99.3			46.9	47.2
Product revenue gross profit as a percent of sales	14.1		%	12.4		%

Kilos sold	197.2			173.5			23.7	13.7
Average price per kilo	$	5.26		$	4.60		0.66	14.3
Average cost per kilo	4.52			4.03			0.49	12.2
Average gross profit per kilo	0.74			0.57			0.17	29.8

Processing and other revenues	$	62.8		$	48.1		14.7	30.6
Processing and other revenues costs of services sold	47.2			35.5			11.7	33.0
Processing and other gross profit	15.6			12.5			3.1	24.8
Processing and other gross profit as a percent of sales	24.8		%	26.1		%

All Other:
Sales and other operating revenues	$	1.8		$	5.6		(3.8)	(67.9)
Cost of goods and services sold	1.8			9.4			(7.6)	(80.9)
Gross loss	—			(3.8)			3.8	100.0
Gross loss as a percent of sales	—		%	(67.8)		%

* Amounts may not equal column totals due to rounding.